| Year |
Citation |
Score |
| 2015 |
Matsuzaki J, Tsuji T, Luescher IF, Shiku H, Mineno J, Okamoto S, Old LJ, Shrikant P, Gnjatic S, Odunsi K. Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses. Scientific Reports. 5: 14896. PMID 26447332 DOI: 10.1038/Srep14896 |
0.433 |
|
| 2015 |
Zanzonico P, Carrasquillo JA, Pandit-Taskar N, O'Donoghue JA, Humm JL, Smith-Jones P, Ruan S, Divgi C, Scott AM, Kemeny NE, Fong Y, Wong D, Scheinberg D, Ritter G, Jungbluth A, ... Old LJ, et al. PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1700-6. PMID 26194713 DOI: 10.1007/S00259-015-3061-2 |
0.412 |
|
| 2014 |
Matsuzaki J, Tsuji T, Luescher I, Old LJ, Shrikant P, Gnjatic S, Odunsi K. Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells. Cancer Immunology Research. 2: 341-50. PMID 24764581 DOI: 10.1158/2326-6066.Cir-13-0138 |
0.457 |
|
| 2013 |
da Cunha JP, Galante PA, de Souza JE, Pieprzyk M, Carraro DM, Old LJ, Camargo AA, de Souza SJ. The human cell surfaceome of breast tumors. Biomed Research International. 2013: 976816. PMID 24195083 DOI: 10.1155/2013/976816 |
0.33 |
|
| 2013 |
Lopes dos Santos M, Yeda FP, Tsuruta LR, Horta BB, Pimenta AA, Degaki TL, Soares IC, Tuma MC, Okamoto OK, Alves VA, Old LJ, Ritter G, Moro AM. Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer. Plos One. 8: e70332. PMID 23936189 DOI: 10.1371/Journal.Pone.0070332 |
0.441 |
|
| 2013 |
von Boehmer L, Mattle M, Bode P, Landshammer A, Schäfer C, Nuber N, Ritter G, Old L, Moch H, Schäfer N, Jäger E, Knuth A, van den Broek M. NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma Cancer Immunity. 13. PMID 23882157 |
0.309 |
|
| 2013 |
Maki RG, Jungbluth AA, Gnjatic S, Schwartz GK, D'Adamo DR, Keohan ML, Wagner MJ, Scheu K, Chiu R, Ritter E, Kachel J, Lowy I, Old LJ, Ritter G. A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma. Sarcoma. 2013: 168145. PMID 23554566 DOI: 10.1155/2013/168145 |
0.413 |
|
| 2013 |
Hirayama M, Nishikawa H, Nagata Y, Tsuji T, Kato T, Kageyama S, Ueda S, Sugiyama D, Hori S, Sakaguchi S, Ritter G, Old LJ, Gnjatic S, Shiku H. Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes. European Journal of Immunology. 43: 989-1000. PMID 23436617 DOI: 10.1002/Eji.201242800 |
0.413 |
|
| 2013 |
Gupta A, Nuber N, Esslinger C, Wittenbrink M, Treder M, Landshammer A, Noguchi T, Kelly M, Gnjatic S, Ritter E, von Boehmer L, Nishikawa H, Shiku H, Old L, Ritter G, et al. A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy. Cancer Immunity. 13: 3. PMID 23390374 |
0.384 |
|
| 2013 |
Ott PA, Carvajal RD, Pandit-Taskar N, Jungbluth AA, Hoffman EW, Wu BW, Bomalaski JS, Venhaus R, Pan L, Old LJ, Pavlick AC, Wolchok JD. Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma. Investigational New Drugs. 31: 425-34. PMID 22864522 DOI: 10.1007/S10637-012-9862-2 |
0.339 |
|
| 2012 |
Sabbatini P, Tsuji T, Ferran L, Ritter E, Sedrak C, Tuballes K, Jungbluth AA, Ritter G, Aghajanian C, Bell-McGuinn K, Hensley ML, Konner J, Tew W, Spriggs DR, Hoffman EW, ... ... Old LJ, et al. Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6497-508. PMID 23032745 DOI: 10.1158/1078-0432.Ccr-12-2189 |
0.42 |
|
| 2012 |
Song MH, Ha JM, Shin DH, Lee CH, Old L, Lee SY. KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis antigen in colon cancer. International Journal of Oncology. 41: 1820-6. PMID 22923163 DOI: 10.3892/ijo.2012.1601 |
0.342 |
|
| 2012 |
Karbach J, Neumann A, Brand K, Wahle C, Siegel E, Maeurer M, Ritter E, Tsuji T, Gnjatic S, Old LJ, Ritter G, Jäger E. Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5449-59. PMID 22847809 DOI: 10.1158/1078-0432.Ccr-12-1116 |
0.367 |
|
| 2012 |
Odunsi K, Matsuzaki J, Karbach J, Neumann A, Mhawech-Fauceglia P, Miller A, Beck A, Morrison CD, Ritter G, Godoy H, Lele S, DuPont N, Edwards R, Shrikant P, Old LJ, et al. Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients Proceedings of the National Academy of Sciences of the United States of America. 109: 5797-5802. PMID 22454499 DOI: 10.1073/Pnas.1117208109 |
0.418 |
|
| 2012 |
Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nature Reviews. Cancer. 12: 278-87. PMID 22437872 DOI: 10.1038/Nrc3236 |
0.39 |
|
| 2012 |
Tsuji T, Matsuzaki J, Caballero OL, Jungbluth AA, Ritter G, Odunsi K, Old LJ, Gnjatic S. Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4 + T cells Journal of Immunology. 188: 3851-3858. PMID 22427632 DOI: 10.4049/Jimmunol.1103269 |
0.416 |
|
| 2012 |
Nishikawa H, Maeda Y, Ishida T, Gnjatic S, Sato E, Mori F, Sugiyama D, Ito A, Fukumori Y, Utsunomiya A, Inagaki H, Old LJ, Ueda R, Sakaguchi S. Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma. Blood. 119: 3097-104. PMID 22323448 DOI: 10.1182/Blood-2011-09-379982 |
0.463 |
|
| 2012 |
Noguchi T, Kato T, Wang L, Maeda Y, Ikeda H, Sato E, Knuth A, Gnjatic S, Ritter G, Sakaguchi S, Old LJ, Shiku H, Nishikawa H. Intracellular tumor-associated antigens represent effective targets for passive immunotherapy. Cancer Research. 72: 1672-82. PMID 22318866 DOI: 10.1158/0008-5472.Can-11-3072 |
0.482 |
|
| 2012 |
Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, Arthur CD, White JM, Chen YS, Shea LK, Hundal J, Wendl MC, Demeter R, Wylie T, Allison JP, ... ... Old LJ, et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature. 482: 400-4. PMID 22318521 DOI: 10.1038/Nature10755 |
0.457 |
|
| 2012 |
Ohue Y, Eikawa S, Okazaki N, Mizote Y, Isobe M, Uenaka A, Fukuda M, Old LJ, Oka M, Nakayama E. Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients. International Journal of Cancer. 131: E649-58. PMID 22109656 DOI: 10.1002/Ijc.27359 |
0.414 |
|
| 2012 |
Kawada J, Wada H, Isobe M, Gnjatic S, Nishikawa H, Jungbluth AA, Okazaki N, Uenaka A, Nakamura Y, Fujiwara S, Mizuno N, Saika T, Ritter E, Yamasaki M, Miyata H, ... ... Old LJ, et al. Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination. International Journal of Cancer. Journal International Du Cancer. 130: 584-92. PMID 21413013 DOI: 10.1002/Ijc.26074 |
0.45 |
|
| 2012 |
Tran S, Ready N, Krug LM, Pietanza MC, Jungbluth AA, Pan LS, Venhaus RR, Hoffman EW, Peters A, Dukelow K, Bomalaski JS, Wu B, Old LJ. Phase II study of ADI-PEG 20 in patients with relapsed sensitive or refractory small cell lung cancer. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E17558 |
0.319 |
|
| 2011 |
Carvajal RD, Gounder MM, Coughlin CM, Fishel J, Heyburn J, O'Shannessy D, Grasso L, Schweizer C, Parno J, Old LJ, Azad NS, Diaz LA. A first-in-human phase I study of MORAb-004 (MOR4), a humanized monoclonal antibody recognizing TEM-1 (endosialin), in patients with solid tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3086. PMID 28022519 DOI: 10.1200/Jco.2011.29.15_Suppl.3086 |
0.411 |
|
| 2011 |
Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, ... ... Old LJ, et al. Defining the critical hurdles in cancer immunotherapy. Journal of Translational Medicine. 9: 214. PMID 22168571 DOI: 10.1186/1479-5876-9-214 |
0.312 |
|
| 2011 |
Junqueira C, Santos LI, Galvão-Filho B, Teixeira SM, Rodrigues FG, DaRocha WD, Chiari E, Jungbluth AA, Ritter G, Gnjatic S, Old LJ, Gazzinelli RT. Trypanosoma cruzi as an effective cancer antigen delivery vector. Proceedings of the National Academy of Sciences of the United States of America. 108: 19695-700. PMID 22114198 DOI: 10.1073/Pnas.1110030108 |
0.457 |
|
| 2011 |
O'Donoghue JA, Smith-Jones PM, Humm JL, Ruan S, Pryma DA, Jungbluth AA, Divgi CR, Carrasquillo JA, Pandit-Taskar N, Fong Y, Strong VE, Kemeny NE, Old LJ, Larson SM. 124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1878-85. PMID 22068895 DOI: 10.2967/Jnumed.111.095596 |
0.432 |
|
| 2011 |
Chen YT, Chiu R, Lee P, Beneck D, Jin B, Old LJ. Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma. Human Reproduction (Oxford, England). 26: 3232-43. PMID 22016418 DOI: 10.1093/Humrep/Der330 |
0.392 |
|
| 2011 |
Yuan J, Adamow M, Ginsberg BA, Rasalan TS, Ritter E, Gallardo HF, Xu Y, Pogoriler E, Terzulli SL, Kuk D, Panageas KS, Ritter G, Sznol M, Halaban R, Jungbluth AA, ... ... Old LJ, et al. Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proceedings of the National Academy of Sciences of the United States of America. 108: 16723-8. PMID 21933959 DOI: 10.1073/Pnas.1110814108 |
0.433 |
|
| 2011 |
Tsuji T, Matsuzaki J, Ritter E, Miliotto A, Ritter G, Odunsi K, Old LJ, Gnjatic S. Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors. Plos One. 6: e23651. PMID 21858191 DOI: 10.1371/Journal.Pone.0023651 |
0.429 |
|
| 2011 |
Carrasquillo JA, Pandit-Taskar N, O'Donoghue JA, Humm JL, Zanzonico P, Smith-Jones PM, Divgi CR, Pryma DA, Ruan S, Kemeny NE, Fong Y, Wong D, Jaggi JS, Scheinberg DA, Gonen M, ... ... Old LJ, et al. (124)I-huA33 antibody PET of colorectal cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1173-80. PMID 21764796 DOI: 10.2967/Jnumed.110.086165 |
0.375 |
|
| 2011 |
von Boehmer L, Keller L, Mortezavi A, Provenzano M, Sais G, Hermanns T, Sulser T, Jungbluth AA, Old LJ, Kristiansen G, van den Broek M, Moch H, Knuth A, Wild PJ. MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer. Plos One. 6: e21366. PMID 21754986 DOI: 10.1371/Journal.Pone.0021366 |
0.317 |
|
| 2011 |
Nicholaou T, Chen W, Davis ID, Jackson HM, Dimopoulos N, Barrow C, Browning J, Macgregor D, Williams D, Hopkins W, Maraskovsky E, Venhaus R, Pan L, Hoffman EW, Old LJ, et al. Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™. Cancer Immunology, Immunotherapy : Cii. 60: 1625-37. PMID 21698545 DOI: 10.1007/S00262-011-1041-3 |
0.411 |
|
| 2011 |
Nardiello T, Jungbluth AA, Mei A, Diliberto M, Huang X, Dabrowski A, Andrade VC, Wasserstrum R, Ely S, Niesvizky R, Pearse R, Coleman M, Jayabalan DS, Bhardwaj N, Old LJ, et al. MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4309-19. PMID 21565982 DOI: 10.1158/1078-0432.Ccr-10-1820 |
0.405 |
|
| 2011 |
Yuan J, Ginsberg B, Page D, Li Y, Rasalan T, Gallardo HF, Xu Y, Adams S, Bhardwaj N, Busam K, Old LJ, Allison JP, Jungbluth A, Wolchok JD. CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases. Cancer Immunology, Immunotherapy : Cii. 60: 1137-46. PMID 21465316 DOI: 10.1007/S00262-011-1011-9 |
0.447 |
|
| 2011 |
Kakimi K, Isobe M, Uenaka A, Wada H, Sato E, Doki Y, Nakajima J, Seto Y, Yamatsuji T, Naomoto Y, Shiraishi K, Takigawa N, Kiura K, Tsuji K, Iwatsuki K, ... ... Old LJ, et al. A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. International Journal of Cancer. 129: 2836-46. PMID 21448901 DOI: 10.1002/Ijc.25955 |
0.372 |
|
| 2011 |
Chen YT, Ross DS, Chiu R, Zhou XK, Chen YY, Lee P, Hoda SA, Simpson AJ, Old LJ, Caballero O, Neville AM. Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers. Plos One. 6: e17876. PMID 21437249 DOI: 10.1371/Journal.Pone.0017876 |
0.38 |
|
| 2011 |
Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science (New York, N.Y.). 331: 1565-70. PMID 21436444 DOI: 10.1126/Science.1203486 |
0.371 |
|
| 2011 |
Pryma DA, O'Donoghue JA, Humm JL, Jungbluth AA, Old LJ, Larson SM, Divgi CR. Correlation of in vivo and in vitro measures of carbonic anhydrase IX antigen expression in renal masses using antibody 124I-cG250. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 535-40. PMID 21421715 DOI: 10.2967/Jnumed.110.083295 |
0.333 |
|
| 2011 |
Lowe AJ, Bardliving CL, Huang CJ, Teixeira LM, Damasceno LM, Anderson KA, Ritter G, Old LJ, Batt CA. Expression and purification of cGMP grade NY-ESO-1 for clinical trials. Biotechnology Progress. 27: 435-41. PMID 21365782 DOI: 10.1002/Btpr.552 |
0.364 |
|
| 2011 |
Karbach J, Neumann A, Atmaca A, Wahle C, Brand K, Von Boehmer L, Knuth A, Bender A, Ritter G, Old LJ, Jäger E. Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naïve prostate cancer patients Clinical Cancer Research. 17: 861-870. PMID 21163871 DOI: 10.1158/1078-0432.Ccr-10-1811 |
0.47 |
|
| 2011 |
Tsuji T, Matsuzaki J, Kelly MP, Ramakrishna V, Vitale L, He LZ, Keler T, Odunsi K, Old LJ, Ritter G, Gnjatic S. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity. Journal of Immunology (Baltimore, Md. : 1950). 186: 1218-27. PMID 21149605 DOI: 10.4049/Jimmunol.1000808 |
0.393 |
|
| 2011 |
Britten CM, Janetzki S, van der Burg SH, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief CJ, O'Donnell-Tormey J, Odunsi K, Old LJ, Pawelec G, Roep BO, Romero P, Hoos A, et al. Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond. Cancer Immunology, Immunotherapy : Cii. 60: 15-22. PMID 21080166 DOI: 10.1007/S00262-010-0940-Z |
0.32 |
|
| 2011 |
Oosterwijk-Wakka JC, Kats-Ugurlu G, Leenders WP, Kiemeney LA, Old LJ, Mulders PF, Oosterwijk E. Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX-specific chimeric monoclonal antibody cG250. Bju International. 107: 118-25. PMID 20346054 DOI: 10.1111/J.1464-410X.2010.09314.X |
0.333 |
|
| 2011 |
Cao Y, Gnjatic S, Brichard VG, Luetkens T, Kobold S, Bartels K, Altorki N, Haag F, Ritter G, Bokemeyer C, Old LJ, Kroeger N, Atanackovic D. Analysis of Spontaneous Vs. Vaccine-Induced Antibody Responses Against Cancer-Testis Antigen MAGE-A3 in Cancer Patients Blood. 118: 5087-5087. DOI: 10.1182/Blood.V118.21.5087.5087 |
0.433 |
|
| 2010 |
Burckhart T, Thiel M, Nishikawa H, Wüest T, Müller D, Zippelius A, Ritter G, Old L, Shiku H, Renner C. Tumor-specific crosslinking of GITR as costimulation for immunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 925-34. PMID 20948444 DOI: 10.1097/CJI.0b013e3181f3cc87 |
0.321 |
|
| 2010 |
Caballero OL, Zhao Q, Rimoldi D, Stevenson BJ, Svobodová S, Devalle S, Röhrig UF, Pagotto A, Michielin O, Speiser D, Wolchok JD, Liu C, Pejovic T, Odunsi K, Brasseur F, ... ... Old LJ, et al. Frequent MAGE mutations in human melanoma. Plos One. 5. PMID 20862285 DOI: 10.1371/Journal.Pone.0012773 |
0.304 |
|
| 2010 |
Konner JA, Bell-McGuinn KM, Sabbatini P, Hensley ML, Tew WP, Pandit-Taskar N, Vander Els N, Phillips MD, Schweizer C, Weil SC, Larson SM, Old LJ. Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5288-95. PMID 20855460 DOI: 10.1158/1078-0432.Ccr-10-0700 |
0.332 |
|
| 2010 |
Muraoka D, Kato T, Wang L, Maeda Y, Noguchi T, Harada N, Takeda K, Yagita H, Guillaume P, Luescher I, Old LJ, Shiku H, Nishikawa H. Peptide vaccine induces enhanced tumor growth associated with apoptosis induction in CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 185: 3768-76. PMID 20733202 DOI: 10.4049/Jimmunol.0903649 |
0.412 |
|
| 2010 |
Ayyoub M, Pignon P, Dojcinovic D, Raimbaud I, Old LJ, Luescher I, Valmori D. Assessment of vaccine-induced CD4 T cell responses to the 119-143 immunodominant region of the tumor-specific antigen NY-ESO-1 using DRB1*0101 tetramers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4607-15. PMID 20670945 DOI: 10.1158/1078-0432.Ccr-10-1485 |
0.424 |
|
| 2010 |
Mitsui J, Nishikawa H, Muraoka D, Wang L, Noguchi T, Sato E, Kondo S, Allison JP, Sakaguchi S, Old LJ, Kato T, Shiku H. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2781-91. PMID 20460483 DOI: 10.1158/1078-0432.Ccr-09-3243 |
0.452 |
|
| 2010 |
Matsuzaki J, Gnjatic S, Mhawech-Fauceglia P, Beck A, Miller A, Tsuji T, Eppolito C, Qian F, Lele S, Shrikant P, Old LJ, Odunsi K. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America. 107: 7875-80. PMID 20385810 DOI: 10.1073/Pnas.1003345107 |
0.403 |
|
| 2010 |
Gnjatic S, Ritter E, Büchler MW, Giese NA, Brors B, Frei C, Murray A, Halama N, Zörnig I, Chen YT, Andrews C, Ritter G, Old LJ, Odunsi K, Jäger D. Seromic profiling of ovarian and pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America. 107: 5088-93. PMID 20194765 DOI: 10.1073/Pnas.0914213107 |
0.397 |
|
| 2010 |
Chen YT, Chadburn A, Lee P, Hsu M, Ritter E, Chiu A, Gnjatic S, Pfreundschuh M, Knowles DM, Old LJ. Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 107: 3093-8. PMID 20133697 DOI: 10.1073/Pnas.0915050107 |
0.324 |
|
| 2010 |
Gnjatic S, Cao Y, Reichelt U, Yekebas EF, Nölker C, Marx AH, Erbersdobler A, Nishikawa H, Hildebrandt Y, Bartels K, Horn C, Stahl T, Gout I, Filonenko V, Ling KL, ... ... Old LJ, et al. NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer. International Journal of Cancer. Journal International Du Cancer. 127: 381-93. PMID 19937794 DOI: 10.1002/Ijc.25058 |
0.454 |
|
| 2010 |
Huang CJ, Anderson KA, Damasceno LM, Ritter G, Old LJ, Batt CA. Improved secretion of the cancer-testis antigen SSX2 in Pichia pastoris by deletion of its nuclear localization signal. Applied Microbiology and Biotechnology. 86: 243-53. PMID 19826807 DOI: 10.1007/S00253-009-2275-2 |
0.348 |
|
| 2010 |
Karbach J, Gnjatic S, Bender A, Neumann A, Weidmann E, Yuan J, Ferrara CA, Hoffmann E, Old LJ, Altorki NK, Jäger E. Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival. International Journal of Cancer. Journal International Du Cancer. 126: 909-18. PMID 19728336 DOI: 10.1002/Ijc.24850 |
0.442 |
|
| 2010 |
White AJ, Coleman RL, Armstrong DK, Glenn D, Bicher A, Richards DA, Schneeweiss A, Old LJ, Schweizer C, Weil S. Efficacy and safety of farletuzumab, a humanized monoclonal antibody to folate receptor alpha, in platinum-sensitive relapsed ovarian cancer subjects: Final data from a multicenter phase II study. Journal of Clinical Oncology. 28: 5001-5001. DOI: 10.1200/Jco.2010.28.15_Suppl.5001 |
0.316 |
|
| 2010 |
Nardiello T, Jungbluth AA, Mei A, DiLiberto M, Huang X, Ely SA, Niesvizky R, Coleman M, Pearse RN, Jayabalan D, Old LJ, Chen-Kiang S, Cho HJ. MAGE-A Inhibits Apoptosis In Proliferating Multiple Myeloma Cells Blood. 116: 785-785. DOI: 10.1182/Blood.V116.21.785.785 |
0.384 |
|
| 2010 |
Maeda Y, Kato T, Wang L, Muraoka D, Sato E, Wolchok JD, Old LJ, Shiku H, Nishikawa H. Abstract 5615: Effects of corticosteroids on tumor immunity induced by anti-CTLA-4 mAb therapy in a mouse model Cancer Research. 70: 5615-5615. DOI: 10.1158/1538-7445.Am10-5615 |
0.428 |
|
| 2010 |
Hirayama M, Nishikawa H, Nagata Y, Tsuji T, Hori S, Aoki M, Ueda S, Tahara H, Kageyama S, Old LJ, Shiku H, Gnjatic S. Abstract 5325: Inhibition of CD4+CD25+ regulatory T cell suppression to anti-tumor responses by OK-432 (lyophilized Streptococcus pyogenes) Cancer Research. 70: 5325-5325. DOI: 10.1158/1538-7445.Am10-5325 |
0.411 |
|
| 2010 |
Kelly MP, Jungbluth AA, Wu B, Bomalaski J, Ritter G, Old LJ. Abstract 4519: Small cell lung cancers lack expression of argininosuccinate synthase (ASS) and are sensitive to arginine deprivation using arginine deiminase-PEG20 (ADI-PEG20) Cancer Research. 70: 4519-4519. DOI: 10.1158/1538-7445.Am10-4519 |
0.418 |
|
| 2010 |
Noguchi T, Kato T, Muraoka D, Ikeda H, Kondo S, Ritter G, Old LJ, Shiku H, Nishikawa H. Abstract 2441: An innovative treatment modality of antibody therapy against intracellular tumor antigens Cancer Research. 70: 2441-2441. DOI: 10.1158/1538-7445.Am10-2441 |
0.489 |
|
| 2009 |
Lin B, White JT, Wu J, Lele S, Old LJ, Hood L, Odunsi K. Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer. Proteomics. Clinical Applications. 3: 853-861. PMID 20559449 DOI: 10.1002/Prca.200800141 |
0.308 |
|
| 2009 |
Lin Y, Gallardo HF, Ku GY, Li H, Manukian G, Rasalan TS, Xu Y, Terzulli SL, Old LJ, Allison JP, Houghton AN, Wolchok JD, Yuan J. Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses. Cytotherapy. 11: 912-22. PMID 19903103 DOI: 10.3109/14653240903136987 |
0.403 |
|
| 2009 |
Janetzki S, Britten CM, Kalos M, Levitsky HI, Maecker HT, Melief CJ, Old LJ, Romero P, Hoos A, Davis MM. "MIATA"-minimal information about T cell assays. Immunity. 31: 527-8. PMID 19833080 DOI: 10.1016/J.Immuni.2009.09.007 |
0.327 |
|
| 2009 |
da Cunha JP, Galante PA, de Souza JE, de Souza RF, Carvalho PM, Ohara DT, Moura RP, Oba-Shinja SM, Marie SK, Silva WA, Perez RO, Stransky B, Pieprzyk M, Moore J, Caballero O, ... ... Old LJ, et al. Bioinformatics construction of the human cell surfaceome. Proceedings of the National Academy of Sciences of the United States of America. 106: 16752-7. PMID 19805368 DOI: 10.1073/Pnas.0907939106 |
0.411 |
|
| 2009 |
Tsuji T, Altorki NK, Ritter G, Old LJ, Gnjatic S. Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination. Journal of Immunology (Baltimore, Md. : 1950). 183: 4800-8. PMID 19734225 DOI: 10.4049/Jimmunol.0900903 |
0.385 |
|
| 2009 |
Grigoriadis A, Caballero OL, Hoek KS, da Silva L, Chen YT, Shin SJ, Jungbluth AA, Miller LD, Clouston D, Cebon J, Old LJ, Lakhani SR, Simpson AJ, Neville AM. CT-X antigen expression in human breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 106: 13493-8. PMID 19651608 DOI: 10.1073/Pnas.0906840106 |
0.374 |
|
| 2009 |
Bioley G, Dousset C, Yeh A, Dupont B, Bhardwaj N, Mears G, Old LJ, Ayyoub M, Valmori D. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4467-74. PMID 19531622 DOI: 10.1158/1078-0432.Ccr-09-0582 |
0.448 |
|
| 2009 |
Qian F, Villella J, Wallace PK, Mhawech-Fauceglia P, Tario JD, Andrews C, Matsuzaki J, Valmori D, Ayyoub M, Frederick PJ, Beck A, Liao J, Cheney R, Moysich K, Lele S, ... ... Old LJ, et al. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer. Cancer Research. 69: 5498-504. PMID 19491279 DOI: 10.1158/0008-5472.Can-08-2106 |
0.37 |
|
| 2009 |
Bauer S, Oosterwijk-Wakka JC, Adrian N, Oosterwijk E, Fischer E, Wüest T, Stenner F, Perani A, Cohen L, Knuth A, Divgi C, Jäger D, Scott AM, Ritter G, Old LJ, et al. Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg. International Journal of Cancer. 125: 115-23. PMID 19384924 DOI: 10.1002/Ijc.24359 |
0.328 |
|
| 2009 |
Gnjatic S, Old LJ, Chen YT. Autoantibodies against cancer antigens. Methods in Molecular Biology (Clifton, N.J.). 520: 11-9. PMID 19381944 DOI: 10.1007/978-1-60327-811-9_2 |
0.429 |
|
| 2009 |
Chen YT, Hsu M, Lee P, Shin SJ, Mhawech-Fauceglia P, Odunsi K, Altorki NK, Song CJ, Jin BQ, Simpson AJ, Old LJ. Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer. International Journal of Cancer. Journal International Du Cancer. 124: 2893-8. PMID 19296537 DOI: 10.1002/Ijc.24296 |
0.358 |
|
| 2009 |
Garrett TP, Burgess AW, Gan HK, Luwor RB, Cartwright G, Walker F, Orchard SG, Clayton AH, Nice EC, Rothacker J, Catimel B, Cavenee WK, Old LJ, Stockert E, Ritter G, et al. Antibodies specifically targeting a locally misfolded region of tumor associated EGFR. Proceedings of the National Academy of Sciences of the United States of America. 106: 5082-7. PMID 19289842 DOI: 10.1073/Pnas.0811559106 |
0.373 |
|
| 2009 |
Gnjatic S, Altorki NK, Tang DN, Tu SM, Kundra V, Ritter G, Old LJ, Logothetis CJ, Sharma P. NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2130-9. PMID 19276258 DOI: 10.1158/1078-0432.Ccr-08-2632 |
0.375 |
|
| 2009 |
Bauer S, Adrian N, Siebenborn U, Fadle N, Plesko M, Fischer E, Wüest T, Stenner F, Mertens JC, Knuth A, Ritter G, Old LJ, Renner C. Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8. Cancer Immunity. 9: 2. PMID 19267427 DOI: 10.5167/Uzh-19531 |
0.303 |
|
| 2009 |
Britten CM, Janetzki S, Ben-Porat L, Clay TM, Kalos M, Maecker H, Odunsi K, Pride M, Old L, Hoos A, Romero P. Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunology, Immunotherapy : Cii. 58: 1701-13. PMID 19259668 DOI: 10.1007/S00262-009-0681-Z |
0.316 |
|
| 2009 |
Leveque L, Deknuydt F, Bioley G, Old LJ, Matsuzaki J, Odunsi K, Ayyoub M, Valmori D. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells. Journal of Immunotherapy (Hagerstown, Md. : 1997). 32: 101-8. PMID 19238008 DOI: 10.1097/Cji.0B013E318195B59E |
0.401 |
|
| 2009 |
Bioley G, Guillaume P, Luescher I, Yeh A, Dupont B, Bhardwaj N, Mears G, Old LJ, Valmori D, Ayyoub M. HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 299-306. PMID 19118058 DOI: 10.1158/1078-0432.Ccr-08-1747 |
0.423 |
|
| 2009 |
Gnjatic S, Wheeler C, Ebner M, Ritter E, Murray A, Altorki NK, Ferrara CA, Hepburne-Scott H, Joyce S, Koopman J, McAndrew MB, Workman N, Ritter G, Fallon R, Old LJ. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays. Journal of Immunological Methods. 341: 50-8. PMID 19041653 DOI: 10.1016/J.Jim.2008.10.016 |
0.459 |
|
| 2009 |
Almeida LG, Sakabe NJ, deOliveira AR, Silva MC, Mundstein AS, Cohen T, Chen YT, Chua R, Gurung S, Gnjatic S, Jungbluth AA, Caballero OL, Bairoch A, Kiesler E, White SL, ... ... Old LJ, et al. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Research. 37: D816-9. PMID 18838390 DOI: 10.1093/Nar/Gkn673 |
0.442 |
|
| 2008 |
Hofmann O, Caballero OL, Stevenson BJ, Chen YT, Cohen T, Chua R, Maher CA, Panji S, Schaefer U, Kruger A, Lehvaslaiho M, Carninci P, Hayashizaki Y, Jongeneel CV, Simpson AJ, ... Old LJ, et al. Genome-wide analysis of cancer/testis gene expression. Proceedings of the National Academy of Sciences of the United States of America. 105: 20422-7. PMID 19088187 DOI: 10.1073/Pnas.0810777105 |
0.337 |
|
| 2008 |
Yuan J, Gnjatic S, Li H, Powel S, Gallardo HF, Ritter E, Ku GY, Jungbluth AA, Segal NH, Rasalan TS, Manukian G, Xu Y, Roman RA, Terzulli SL, Heywood M, ... ... Old LJ, et al. CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Proceedings of the National Academy of Sciences of the United States of America. 105: 20410-5. PMID 19074257 DOI: 10.1073/Pnas.0810114105 |
0.315 |
|
| 2008 |
Sharma P, Bajorin DF, Jungbluth AA, Herr H, Old LJ, Gnjatic S. Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF. Journal of Immunotherapy (Hagerstown, Md. : 1997). 31: 849-57. PMID 18833002 DOI: 10.1097/Cji.0B013E3181891574 |
0.414 |
|
| 2008 |
Wada H, Sato E, Uenaka A, Isobe M, Kawabata R, Nakamura Y, Iwae S, Yonezawa K, Yamasaki M, Miyata H, Doki Y, Shiku H, Jungbluth AA, Ritter G, Murphy R, ... ... Old LJ, et al. Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination. International Journal of Cancer. 123: 2362-9. PMID 18729190 DOI: 10.1002/Ijc.23810 |
0.426 |
|
| 2008 |
Nishikawa H, Kato T, Hirayama M, Orito Y, Sato E, Harada N, Gnjatic S, Old LJ, Shiku H. Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling. Cancer Research. 68: 5948-54. PMID 18632650 DOI: 10.1158/0008-5472.Can-07-5839 |
0.411 |
|
| 2008 |
Howland SW, Tsuji T, Gnjatic S, Ritter G, Old LJ, Wittrup KD. Inducing efficient cross-priming using antigen-coated yeast particles. Journal of Immunotherapy (Hagerstown, Md. : 1997). 31: 607-19. PMID 18600183 DOI: 10.1097/Cji.0B013E318181C87F |
0.419 |
|
| 2008 |
Diefenbach CS, Gnjatic S, Sabbatini P, Aghajanian C, Hensley ML, Spriggs DR, Iasonos A, Lee H, Dupont B, Pezzulli S, Jungbluth AA, Old LJ, Dupont J. Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2740-8. PMID 18451240 DOI: 10.1158/1078-0432.Ccr-07-4619 |
0.349 |
|
| 2008 |
Smith-Jones PM, Pandit-Taskar N, Cao W, O'Donoghue J, Philips MD, Carrasquillo J, Konner JA, Old LJ, Larson SM. Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003. Nuclear Medicine and Biology. 35: 343-51. PMID 18355690 DOI: 10.1016/J.Nucmedbio.2007.12.008 |
0.32 |
|
| 2008 |
Tsuji K, Hamada T, Uenaka A, Wada H, Sato E, Isobe M, Asagoe K, Yamasaki O, Shiku H, Ritter G, Murphy R, Hoffman EW, Old LJ, Nakayama E, Iwatsuki K. Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient. Cancer Immunology, Immunotherapy : Cii. 57: 1429-37. PMID 18311489 DOI: 10.1007/S00262-008-0478-5 |
0.416 |
|
| 2008 |
Matsuzaki J, Qian F, Luescher I, Lele S, Ritter G, Shrikant PA, Gnjatic S, Old LJ, Odunsi K. Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1. Cancer Immunology, Immunotherapy : Cii. 57: 1185-95. PMID 18253733 DOI: 10.1007/S00262-008-0450-4 |
0.422 |
|
| 2008 |
Oosterwijk E, Boerman OC, Oyen WJ, Old LJ, Mulders PF. Antibody therapy in renal cell carcinoma. World Journal of Urology. 26: 141-6. PMID 18239922 DOI: 10.1007/S00345-008-0236-5 |
0.32 |
|
| 2008 |
Ackerman ME, Chalouni C, Schmidt MM, Raman VV, Ritter G, Old LJ, Mellman I, Wittrup KD. A33 antigen displays persistent surface expression. Cancer Immunology, Immunotherapy : Cii. 57: 1017-27. PMID 18236042 DOI: 10.1007/S00262-007-0433-X |
0.419 |
|
| 2008 |
Atanackovic D, Altorki NK, Cao Y, Ritter E, Ferrara CA, Ritter G, Hoffman EW, Bokemeyer C, Old LJ, Gnjatic S. Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming. Proceedings of the National Academy of Sciences of the United States of America. 105: 1650-5. PMID 18216244 DOI: 10.1073/Pnas.0707140104 |
0.379 |
|
| 2008 |
Tosello V, Odunsi K, Souleimanian NE, Lele S, Shrikant P, Old LJ, Valmori D, Ayyoub M. Differential expression of CCR7 defines two distinct subsets of human memory CD4+CD25+ Tregs. Clinical Immunology (Orlando, Fla.). 126: 291-302. PMID 18166500 DOI: 10.1016/J.Clim.2007.11.008 |
0.33 |
|
| 2008 |
Kageyama S, Kitano S, Hirayama M, Nagata Y, Imai H, Shiraishi T, Akiyoshi K, Scott AM, Murphy R, Hoffman EW, Old LJ, Katayama N, Shiku H. Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel. Cancer Science. 99: 601-7. PMID 18081877 DOI: 10.1111/J.1349-7006.2007.00705.X |
0.366 |
|
| 2008 |
Nishikawa H, Tsuji T, Jäger E, Briones G, Ritter G, Old LJ, Galán JE, Shiku H, Gnjatic S. Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector. Blood. 111: 1404-12. PMID 17986662 DOI: 10.1182/Blood-2007-09-113761 |
0.385 |
|
| 2007 |
Perera RM, Zoncu R, Johns TG, Pypaert M, Lee FT, Mellman I, Old LJ, Toomre DK, Scott AM. Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody. Neoplasia (New York, N.Y.). 9: 1099-110. PMID 18084617 DOI: 10.1593/Neo.07721 |
0.399 |
|
| 2007 |
Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM, Thompson TC, Old LJ, Wang RF. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 6947-58. PMID 18056169 DOI: 10.1158/1078-0432.Ccr-07-0842 |
0.349 |
|
| 2007 |
Szmania S, Gnjatic S, Tricot G, Stone K, Zhan F, Moreno A, Thuro B, Melenhorst J, Barrett J, Shaughnessy J, Old LJ, Barlogie B, Brichard VG, van Rhee F. Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myeloma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 30: 847-54. PMID 18049337 DOI: 10.1097/Cji.0B013E318158Fcff |
0.351 |
|
| 2007 |
Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD. Adaptive immunity maintains occult cancer in an equilibrium state. Nature. 450: 903-7. PMID 18026089 DOI: 10.1038/Nature06309 |
0.375 |
|
| 2007 |
Silva WA, Gnjatic S, Ritter E, Chua R, Cohen T, Hsu M, Jungbluth AA, Altorki NK, Chen YT, Old LJ, Simpson AJ, Caballero OL. PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses. Cancer Immunity. 7: 18. PMID 17983203 |
0.326 |
|
| 2007 |
Bender A, Karbach J, Neumann A, Jäger D, Al-Batran SE, Atmaca A, Weidmann E, Biskamp M, Gnjatic S, Pan L, Hoffman E, Old LJ, Knuth A, Jäger E. LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer. Cancer Immunity. 7: 16. PMID 17944437 |
0.316 |
|
| 2007 |
Huang CJ, Chen RH, Vannelli T, Lee F, Ritter E, Ritter G, Old LJ, Batt CA. Expression and purification of the cancer antigen SSX2: a potential cancer vaccine. Protein Expression and Purification. 56: 212-9. PMID 17931884 DOI: 10.1016/J.Pep.2007.07.009 |
0.415 |
|
| 2007 |
Krug LM, Milton DT, Jungbluth AA, Chen LC, Quaia E, Pandit-Taskar N, Nagel A, Jones J, Kris MG, Finn R, Smith-Jones P, Scott AM, Old L, Divgi C. Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 2: 947-52. PMID 17909358 DOI: 10.1097/JTO.0b013e3181560dcc |
0.302 |
|
| 2007 |
Odunsi K, Qian F, Matsuzaki J, Mhawech-Fauceglia P, Andrews C, Hoffman EW, Pan L, Ritter G, Villella J, Thomas B, Rodabaugh K, Lele S, Shrikant P, Old LJ, Gnjatic S. Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer Proceedings of the National Academy of Sciences of the United States of America. 104: 12837-12842. PMID 17652518 DOI: 10.1073/Pnas.0703342104 |
0.435 |
|
| 2007 |
Karbach J, Gnjatic S, Pauligk C, Bender A, Maeurer M, Schultze JL, Nadler K, Wahle C, Knuth A, Old LJ, Jäger E. Tumor‐reactive CD8+ T‐cell clones in patients after NY‐ESO‐1 peptide vaccination International Journal of Cancer. 121: 2042-2048. PMID 17640060 DOI: 10.1002/Ijc.22957 |
0.444 |
|
| 2007 |
Scott AM, Tebbutt N, Lee FT, Cavicchiolo T, Liu Z, Gill S, Poon AM, Hopkins W, Smyth FE, Murone C, MacGregor D, Papenfuss AT, Chappell B, Saunder TH, Brechbiel MW, ... ... Old LJ, et al. A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3286-92. PMID 17545534 DOI: 10.1158/1078-0432.Ccr-07-0284 |
0.409 |
|
| 2007 |
Jäger D, Filonenko V, Gout I, Frosina D, Eastlake-Wade S, Castelli S, Varga Z, Moch H, Chen Y, Busam KJ, Seil I, Old LJ, Nissan A, Frei C, Gure AO, et al. NY-BR-1 is a differentiation antigen of the mammary gland. Applied Immunohistochemistry & Molecular Morphology. 15: 77-83. PMID 17536312 DOI: 10.1097/01.Pai.0000213111.05108.A0 |
0.346 |
|
| 2007 |
Stevenson BJ, Iseli C, Panji S, Zahn-Zabal M, Hide W, Old LJ, Simpson AJ, Jongeneel CV. Rapid evolution of cancer/testis genes on the X chromosome. Bmc Genomics. 8: 129. PMID 17521433 DOI: 10.1186/1471-2164-8-129 |
0.341 |
|
| 2007 |
Valmori D, Souleimanian NE, Tosello V, Bhardwaj N, Adams S, O'Neill D, Pavlick A, Escalon JB, Cruz CM, Angiulli A, Angiulli F, Mears G, Vogel SM, Pan L, Jungbluth AA, ... ... Old LJ, et al. Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming. Proceedings of the National Academy of Sciences of the United States of America. 104: 8947-52. PMID 17517626 DOI: 10.1073/Pnas.0703395104 |
0.441 |
|
| 2007 |
Uenaka A, Wada H, Isobe M, Saika T, Tsuji K, Sato E, Sato S, Noguchi Y, Kawabata R, Yasuda T, Doki Y, Kumon H, Iwatsuki K, Shiku H, Monden M, ... ... Old LJ, et al. T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. Cancer Immunity. 7: 9. PMID 17441676 |
0.319 |
|
| 2007 |
Divgi CR, Pandit-Taskar N, Jungbluth AA, Reuter VE, Gönen M, Ruan S, Pierre C, Nagel A, Pryma DA, Humm J, Larson SM, Old LJ, Russo P. Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. The Lancet. Oncology. 8: 304-10. PMID 17395103 DOI: 10.1016/S1470-2045(07)70044-X |
0.309 |
|
| 2007 |
Sharma P, Old LJ, Allison JP. Immunotherapeutic strategies for high-risk bladder cancer. Seminars in Oncology. 34: 165-72. PMID 17382800 DOI: 10.1053/J.Seminoncol.2006.12.004 |
0.337 |
|
| 2007 |
Scott AM, Lee FT, Tebbutt N, Herbertson R, Gill SS, Liu Z, Skrinos E, Murone C, Saunder TH, Chappell B, Papenfuss AT, Poon AM, Hopkins W, Smyth FE, MacGregor D, ... ... Old LJ, et al. A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors. Proceedings of the National Academy of Sciences of the United States of America. 104: 4071-6. PMID 17360479 DOI: 10.1073/Pnas.0611693104 |
0.451 |
|
| 2007 |
Sharma P, Shen Y, Wen S, Yamada S, Jungbluth AA, Gnjatic S, Bajorin DF, Reuter VE, Herr H, Old LJ, Sato E. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 104: 3967-72. PMID 17360461 DOI: 10.1073/Pnas.0611618104 |
0.398 |
|
| 2007 |
Ebel W, Routhier EL, Foley B, Jacob S, McDonough JM, Patel RK, Turchin HA, Chao Q, Kline JB, Old LJ, Phillips MD, Nicolaides NC, Sass PM, Grasso L. Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. Cancer Immunity. 7: 6. PMID 17346028 |
0.344 |
|
| 2007 |
Kawabata R, Wada H, Isobe M, Saika T, Sato S, Uenaka A, Miyata H, Yasuda T, Doki Y, Noguchi Y, Kumon H, Tsuji K, Iwatsuki K, Shiku H, Ritter G, ... ... Old LJ, et al. Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients International Journal of Cancer. 120: 2178-2184. PMID 17278093 DOI: 10.1002/Ijc.22583 |
0.428 |
|
| 2007 |
Li D, Ji H, Zaghlul S, McNamara K, Liang MC, Shimamura T, Kubo S, Takahashi M, Chirieac LR, Padera RF, Scott AM, Jungbluth AA, Cavenee WK, Old LJ, Demetri GD, et al. Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomas. The Journal of Clinical Investigation. 117: 346-52. PMID 17256054 DOI: 10.1172/Jci30446 |
0.329 |
|
| 2007 |
Damasceno LM, Anderson KA, Ritter G, Cregg JM, Old LJ, Batt CA. Cooverexpression of chaperones for enhanced secretion of a single-chain antibody fragment in Pichia pastoris. Applied Microbiology and Biotechnology. 74: 381-9. PMID 17051412 DOI: 10.1007/S00253-006-0652-7 |
0.305 |
|
| 2007 |
Atanackovic D, Arfsten J, Cao Y, Gnjatic S, Schnieders F, Bartels K, Schilling G, Faltz C, Wolschke C, Dierlamm J, Ritter G, Eiermann T, Hossfeld DK, Zander AR, Jungbluth AA, ... Old LJ, et al. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation Blood. 109: 1103-1112. PMID 17023585 DOI: 10.1182/Blood-2006-04-014480 |
0.42 |
|
| 2007 |
Zippelius A, Gati A, Bartnick T, Walton S, Odermatt B, Jaeger E, Dummer R, Urosevic M, Filonenko V, Osanai K, Moch H, Chen YT, Old LJ, Knuth A, Jaeger D. Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients. Cancer Immunology, Immunotherapy : Cii. 56: 249-58. PMID 16718472 DOI: 10.1007/S00262-006-0177-Z |
0.462 |
|
| 2006 |
Scott AM, Gill SS, Lee F, Liu Z, Skrinos E, Murone C, Saunder T, Chappell B, Papenfuss A, Old LJ. A phase I single dose escalation trial of ch806 in patients with advanced tumors expressing the 806 antigen. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 13028. PMID 27955576 DOI: 10.1200/Jco.2006.24.18_Suppl.13028 |
0.384 |
|
| 2006 |
Kitano S, Kageyama S, Nagata Y, Miyahara Y, Hiasa A, Naota H, Okumura S, Imai H, Shiraishi T, Masuya M, Nishikawa M, Sunamoto J, Akiyoshi K, Kanematsu T, Scott AM, ... ... Old LJ, et al. HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 7397-405. PMID 17189412 DOI: 10.1158/1078-0432.Ccr-06-1546 |
0.436 |
|
| 2006 |
Sakamoto J, Oriuchi N, Mochiki E, Asao T, Scott AM, Hoffman EW, Jungbluth AA, Matsui T, Lee FT, Papenfuss A, Kuwano H, Takahashi T, Endo K, Old LJ. A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma. Cancer Science. 97: 1248-54. PMID 17034367 DOI: 10.1111/J.1349-7006.2006.00324.X |
0.374 |
|
| 2006 |
Sharma P, Shen Y, Wen S, Bajorin DF, Reuter VE, Old LJ, Jungbluth AA. Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 5442-7. PMID 17000678 DOI: 10.1158/1078-0432.Ccr-06-0527 |
0.42 |
|
| 2006 |
Jäger E, Karbach J, Gnjatic S, Neumann A, Bender A, Valmori D, Ayyoub M, Ritter E, Ritter G, Jäger D, Panicali D, Hoffman E, Pan L, Oettgen H, Old LJ, et al. Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients. Proceedings of the National Academy of Sciences of the United States of America. 103: 14453-8. PMID 16984998 DOI: 10.1073/Pnas.0606512103 |
0.42 |
|
| 2006 |
Davis ID, Chen Q, Morris L, Quirk J, Stanley M, Tavarnesi ML, Parente P, Cavicchiolo T, Hopkins W, Jackson H, Dimopoulos N, Tai TY, MacGregor D, Browning J, Svobodova S, ... ... Old LJ, et al. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients. Journal of Immunotherapy (Hagerstown, Md. : 1997). 29: 499-511. PMID 16971806 DOI: 10.1097/01.Cji.0000211299.29632.8C |
0.435 |
|
| 2006 |
Tammela J, Uenaka A, Ono T, Noguchi Y, Jungbluth AA, Mhawech-Fauceglia P, Qian F, Schneider S, Sharma S, Driscoll D, Lele S, Old LJ, Nakayama E, Odunsi K. OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer. International Journal of Oncology. 29: 903-10. PMID 16964386 |
0.337 |
|
| 2006 |
Bauer S, Adrian N, Fischer E, Kleber S, Stenner F, Wadle A, Fadle N, Zoellner A, Bernhardt R, Knuth A, Old LJ, Renner C. Structure-activity profiles of Ab-derived TNF fusion proteins. Journal of Immunology (Baltimore, Md. : 1950). 177: 2423-30. PMID 16888004 DOI: 10.4049/Jimmunol.177.4.2423 |
0.303 |
|
| 2006 |
Nakamura S, Nouso K, Noguchi Y, Higashi T, Ono T, Jungbluth A, Chen YT, Old LJ, Nakayama E, Shiratori Y. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 21: 1281-1285. PMID 16872310 DOI: 10.1111/J.1440-1746.2006.04271.X |
0.314 |
|
| 2006 |
Gnjatic S, Nishikawa H, Jungbluth AA, Güre AO, Ritter G, Jäger E, Knuth A, Chen Y, Old LJ. NY-ESO-1: review of an immunogenic tumor antigen. Advances in Cancer Research. 95: 1-30. PMID 16860654 DOI: 10.1016/S0065-230X(06)95001-5 |
0.422 |
|
| 2006 |
Godefroy E, Scotto L, Souleimanian NE, Ritter G, Old LJ, Jotereau F, Valmori D, Ayyoub M. Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles. Clinical Immunology (Orlando, Fla.). 121: 54-62. PMID 16814609 DOI: 10.1016/J.CLIM.2006.05.007 |
0.339 |
|
| 2006 |
Nishikawa H, Sato E, Briones G, Chen LM, Matsuo M, Nagata Y, Ritter G, Jäger E, Nomura H, Kondo S, Tawara I, Kato T, Shiku H, Old LJ, Galán JE, et al. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. The Journal of Clinical Investigation. 116: 1946-54. PMID 16794737 DOI: 10.1172/Jci28045 |
0.452 |
|
| 2006 |
Hicks AM, Riedlinger G, Willingham MC, Alexander-Miller MA, Von Kap-Herr C, Pettenati MJ, Sanders AM, Weir HM, Du W, Kim J, Simpson AJ, Old LJ, Cui Z. Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proceedings of the National Academy of Sciences of the United States of America. 103: 7753-8. PMID 16682640 DOI: 10.1073/Pnas.0602382103 |
0.338 |
|
| 2006 |
Varga Z, Theurillat JP, Filonenko V, Sasse B, Odermatt B, Jungbluth AA, Chen YT, Old LJ, Knuth A, Jäger D, Moch H. Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases Clinical Cancer Research. 12: 2745-2751. PMID 16675566 DOI: 10.1158/1078-0432.Ccr-05-2192 |
0.366 |
|
| 2006 |
Nishikawa H, Qian F, Tsuji T, Ritter G, Old LJ, Gnjatic S, Odunsi K. Influence of CD4+CD25+ Regulatory T Cells on Low/High-Avidity CD4+ T Cells following Peptide Vaccination Journal of Immunology. 176: 6340-6346. PMID 16670346 DOI: 10.4049/Jimmunol.176.10.6340 |
0.365 |
|
| 2006 |
Jackson H, Dimopoulos N, Mifsud NA, Tai TY, Chen Q, Svobodova S, Browning J, Luescher I, Stockert L, Old LJ, Davis ID, Cebon J, Chen W. Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1. Journal of Immunology (Baltimore, Md. : 1950). 176: 5908-17. PMID 16670298 DOI: 10.4049/Jimmunol.176.10.5908 |
0.416 |
|
| 2006 |
Piatesi A, Howland SW, Rakestraw JA, Renner C, Robson N, Cebon J, Maraskovsky E, Ritter G, Old L, Wittrup KD. Directed evolution for improved secretion of cancer-testis antigen NY-ESO-1 from yeast. Protein Expression and Purification. 48: 232-42. PMID 16563796 DOI: 10.1016/J.Pep.2006.01.026 |
0.332 |
|
| 2006 |
Hasegawa K, Noguchi Y, Koizumi F, Uenaka A, Tanaka M, Shimono M, Nakamura H, Shiku H, Gnjatic S, Murphy R, Hiramatsu Y, Old LJ, Nakayama E. In vitro Stimulation of CD8 and CD4 T Cells by Dendritic Cells Loaded with a Complex of Cholesterol-Bearing Hydrophobized Pullulan and NY-ESO-1 Protein: Identification of a New HLA-DR15–Binding CD4 T-Cell Epitope Clinical Cancer Research. 12: 1921-1927. PMID 16551878 DOI: 10.1158/1078-0432.Ccr-05-1900 |
0.387 |
|
| 2006 |
Valmori D, Qian F, Ayyoub M, Renner C, Merlo A, Gnjatic S, Gjnatic S, Stockert E, Driscoll D, Lele S, Old LJ, Odunsi K. Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 398-404. PMID 16428478 DOI: 10.1158/1078-0432.Ccr-05-1902 |
0.425 |
|
| 2006 |
Chen YT, Iseli C, Venditti CA, Old LJ, Simpson AJ, Jongeneel CV. Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome. Genes, Chromosomes & Cancer. 45: 392-400. PMID 16382448 DOI: 10.1002/Gcc.20298 |
0.331 |
|
| 2006 |
Karbach J, Pauligk C, Bender A, Gnjatic S, Franzmann K, Wahle C, Jäger D, Knuth A, Old LJ, Jäger E. Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011. International Journal of Cancer. 118: 668-674. PMID 16152624 DOI: 10.1002/Ijc.21391 |
0.435 |
|
| 2006 |
Tammela J, Uenaka A, Ono T, Noguchi Y, Jungbluth AA, Mhawech-Fauceglia P, Qian F, Schneider S, Sharma S, Driscoll D, Lele S, Old LJ, Nakayama E, Odunsi K. OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer International Journal of Oncology. 29: 903-910. DOI: 10.3892/Ijo.29.4.903 |
0.445 |
|
| 2006 |
Nicholaou T, Davis ID, Marakovsky E, Miloradovic L, Hopkins W, Chen W, McArthur G, Pan L, Hoffman EW, Old LJ, Cebon J. Phase II trial of vaccination with full length NY-ESO-1/IMX in patients with advanced malignant melanoma Journal of Clinical Oncology. 24: 2571-2571. DOI: 10.1200/Jco.2006.24.18_Suppl.2571 |
0.354 |
|
| 2006 |
Lendvai N, Gnjatic S, Ritter E, Chen Y, Coughlin C, Vonderheide RH, Niesvizky R, Bhardwaj N, Chen-Kiang S, Old LJ, Cho HJ. Host Immune Responses Against CT Antigens in Multiple Myeloma Patients. Blood. 108: 3492-3492. DOI: 10.1182/Blood.V108.11.3492.3492 |
0.409 |
|
| 2006 |
Cho HJ, Ely S, Austin WR, Niesvizky R, Pearse R, Coleman M, Bhardwaj N, DiLiberto M, Chen-Kiang S, Old LJ, Jungbluth AA. Differential Expression of Type I MAGE in New and Relapsed Multiple Myeloma: Evidence for Association with Proliferation and Progression of Disease. Blood. 108: 3397-3397. DOI: 10.1182/Blood.V108.11.3397.3397 |
0.414 |
|
| 2006 |
Old LJ, Boyse EA, Clarke DA, Carswell EA. Antigenic Properties Of Chemically Induced Tumors Annals of the New York Academy of Sciences. 101: 80-106. DOI: 10.1111/J.1749-6632.1962.Tb26446.X |
0.362 |
|
| 2005 |
Ayyoub M, Souleimanian NE, Godefroy E, Scotto L, Hesdorffer CS, Old LJ, Valmori D. A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients. Clinical Immunology (Orlando, Fla.). 118: 188-94. PMID 16368270 DOI: 10.1016/j.clim.2005.10.002 |
0.352 |
|
| 2005 |
Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, ... ... Old LJ, et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proceedings of the National Academy of Sciences of the United States of America. 102: 18538-18543. PMID 16344461 DOI: 10.1073/Pnas.0509182102 |
0.348 |
|
| 2005 |
Jäger D, Karbach J, Pauligk C, Seil I, Frei C, Chen YT, Old LJ, Knuth A, Jäger E. Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes. Cancer Immunity. 5: 11. PMID 16335914 |
0.345 |
|
| 2005 |
Gure AO, Chua R, Williamson B, Gonen M, Ferrera CA, Gnjatic S, Ritter G, Simpson AJ, Chen YT, Old LJ, Altorki NK. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 8055-62. PMID 16299236 DOI: 10.1158/1078-0432.Ccr-05-1203 |
0.348 |
|
| 2005 |
Nishikawa H, Kato T, Tawara I, Ikeda H, Kuribayashi K, Allen PM, Schreiber RD, Old LJ, Shiku H. IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response. Journal of Immunology (Baltimore, Md. : 1950). 175: 4433-40. PMID 16177085 DOI: 10.4049/Jimmunol.175.7.4433 |
0.354 |
|
| 2005 |
Perera RM, Narita Y, Furnari FB, Gan HK, Murone C, Ahlkvist M, Luwor RB, Burgess AW, Stockert E, Jungbluth AA, Old LJ, Cavenee WK, Scott AM, Johns TG. Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6390-9. PMID 16144944 DOI: 10.1158/1078-0432.Ccr-04-2653 |
0.383 |
|
| 2005 |
Valmori D, Souleimanian NE, Hesdorffer CS, Old LJ, Ayyoub M. Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals. Clinical Immunology (Orlando, Fla.). 117: 161-7. PMID 16103015 DOI: 10.1016/j.clim.2005.07.004 |
0.301 |
|
| 2005 |
Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nature Reviews. Cancer. 5: 615-25. PMID 16034368 DOI: 10.1038/Nrc1669 |
0.42 |
|
| 2005 |
Sharma S, Qian F, Keitz B, Driscoll D, Scanlan MJ, Skipper J, Rodabaugh K, Lele S, Old LJ, Odunsi K. A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer. Gynecologic Oncology. 99: 183-8. PMID 16005946 DOI: 10.1016/J.Ygyno.2005.06.006 |
0.386 |
|
| 2005 |
Chong G, Lee FT, Hopkins W, Tebbutt N, Cebon JS, Mountain AJ, Chappell B, Papenfuss A, Schleyer P, U P, Murphy R, Wirth V, Smyth FE, Potasz N, Poon A, ... ... Old LJ, et al. Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4818-26. PMID 16000579 DOI: 10.1158/1078-0432.Ccr-04-2330 |
0.368 |
|
| 2005 |
Scott AM, Lee FT, Jones R, Hopkins W, MacGregor D, Cebon JS, Hannah A, Chong G, U P, Papenfuss A, Rigopoulos A, Sturrock S, Murphy R, Wirth V, Murone C, ... ... Old LJ, et al. A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4810-7. PMID 16000578 DOI: 10.1158/1078-0432.Ccr-04-2329 |
0.402 |
|
| 2005 |
Valmori D, Souleimanian NE, Hesdorffer CS, Ritter G, Old LJ, Ayyoub M. Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses. Clinical Immunology. 117: 24-30. PMID 15994128 DOI: 10.1016/J.Clim.2005.05.003 |
0.482 |
|
| 2005 |
Nishikawa H, Kato T, Tawara I, Takemitsu T, Saito K, Wang L, Ikarashi Y, Wakasugi H, Nakayama T, Taniguchi M, Kuribayashi K, Old LJ, Shiku H. Accelerated chemically induced tumor development mediated by CD4 + CD25 + regulatory T cells in wild-type hosts Proceedings of the National Academy of Sciences of the United States of America. 102: 9253-9257. PMID 15961541 DOI: 10.1073/Pnas.0503852102 |
0.4 |
|
| 2005 |
Chen YT, Scanlan MJ, Venditti CA, Chua R, Theiler G, Stevenson BJ, Iseli C, Gure AO, Vasicek T, Strausberg RL, Jongeneel CV, Old LJ, Simpson AJ. Identification of cancer/testis-antigen genes by massively parallel signature sequencing. Proceedings of the National Academy of Sciences of the United States of America. 102: 7940-5. PMID 15905330 DOI: 10.1073/Pnas.0502583102 |
0.363 |
|
| 2005 |
Murphy R, Green S, Ritter G, Cohen L, Ryan D, Woods W, Rubira M, Cebon J, Davis ID, Sjolander A, Kypridis A, Kalnins H, McNamara M, Moloney MB, Ackland J, ... ... Old LJ, et al. Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions. Preparative Biochemistry & Biotechnology. 35: 119-34. PMID 15881594 DOI: 10.1081/Pb-200054732 |
0.367 |
|
| 2005 |
Wadle A, Mischo A, Imig J, Wüllner B, Hensel D, Wätzig K, Neumann F, Kubuschok B, Schmidt W, Old LJ, Pfreundschuh M, Renner C. Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library International Journal of Cancer. 117: 104-113. PMID 15880534 DOI: 10.1002/Ijc.21147 |
0.375 |
|
| 2005 |
Nishikawa H, Jäger E, Ritter G, Old LJ, Gnjatic S. CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients. Blood. 106: 1008-1011. PMID 15840697 DOI: 10.1182/Blood-2005-02-0607 |
0.384 |
|
| 2005 |
Dunn GP, Sheehan KC, Old LJ, Schreiber RD. IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression. Cancer Research. 65: 3447-53. PMID 15833880 DOI: 10.1158/0008-5472.Can-04-4316 |
0.332 |
|
| 2005 |
Ayyoub M, Merlo A, Hesdorffer CS, Rimoldi D, Speiser D, Cerottini J, Chen Y, Old LJ, Stevanovic S, Valmori D. CD4+ T Cell Responses to SSX-4 in Melanoma Patients Journal of Immunology. 174: 5092-5099. PMID 15814740 DOI: 10.4049/Jimmunol.174.8.5092 |
0.437 |
|
| 2005 |
Johns TG, Mellman I, Cartwright GA, Ritter G, Old LJ, Burgess AW, Scott AM. The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 780-2. PMID 15774576 DOI: 10.1096/Fj.04-1766Fje |
0.324 |
|
| 2005 |
Panousis C, Rayzman VM, Johns TG, Renner C, Liu Z, Cartwright G, Lee FT, Wang D, Gan H, Cao D, Kypridis A, Smyth FE, Brechbiel MW, Burgess AW, Old LJ, et al. Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR. British Journal of Cancer. 92: 1069-77. PMID 15770208 DOI: 10.1038/Sj.Bjc.6602470 |
0.334 |
|
| 2005 |
Jungbluth AA, Ely S, DiLiberto M, Niesvizky R, Williamson B, Frosina D, Chen YT, Bhardwaj N, Chen-Kiang S, Old LJ, Cho HJ. The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation. Blood. 106: 167-74. PMID 15761016 DOI: 10.1182/Blood-2004-12-4931 |
0.385 |
|
| 2005 |
Nishikawa H, Kato T, Tawara I, Saito K, Ikeda H, Kuribayashi K, Allen PM, Schreiber RD, Sakaguchi S, Old LJ, Shiku H. Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells. The Journal of Experimental Medicine. 201: 681-6. PMID 15753203 DOI: 10.1084/Jem.20041959 |
0.387 |
|
| 2005 |
Ayyoub M, Merlo A, Hesdorffer CS, Speiser D, Rimoldi D, Cerottini JC, Ritter G, Chen YT, Old LJ, Stevanovic S, Valmori D. Distinct but overlapping T helper epitopes in the 37–58 region of SSX-2 Clinical Immunology. 114: 70-78. PMID 15596411 DOI: 10.1016/J.Clim.2004.08.014 |
0.436 |
|
| 2005 |
Cho HJ, Caballero O, Jungbluth AA, DiLiberto M, Niesvizky R, Old LJ, Chen-Kiang S. Type I MAGE Proteins: Novel Markers of Proliferation in Multiple Myeloma Progenitor Cells. Blood. 106: 5115-5115. DOI: 10.1182/Blood.V106.11.5115.5115 |
0.43 |
|
| 2005 |
Cho HJ, Farol L, Truong JT, Austin WR, Chen Y, Bhardwaj N, Niesvizky R, Old LJ, Chen-Kiang S. CT7 (MAGE-C1)-Specific Cellular Immune Responses in the Bone Marrow Microenvironment of Multiple Myeloma Patients. Blood. 106: 356-356. DOI: 10.1182/Blood.V106.11.356.356 |
0.378 |
|
| 2005 |
Sharma P, Bajorin DF, Altorki NK, Nishikawa H, Old LJ, Gnjatic S. Protein and DNA-Based Vaccines With the NY-ESO-1 Antigen in Cancer Patients Journal of Immunotherapy. 28: 659. DOI: 10.1097/01.Cji.0000191101.58195.2A |
0.342 |
|
| 2005 |
Chen W, Jackson H, Dimopoulos N, Tai TY, Mifsud NA, Chen Q, Miloradovic L, Maraskovsky E, Luescher I, Old LJ, Davis ID, Cebon JS. Systematic Analysis of Anti-NY-ESO-1 T Cell Responses Reveals Striking HLA-Dependent Immunodominance Journal of Immunotherapy. 28: 629. DOI: 10.1097/01.Cji.0000191002.32234.67 |
0.364 |
|
| 2005 |
Davis ID, Chen W, Jackson H, Parente P, Shackleton M, Hopkins W, Chen Q, Dimopoulos N, Luke T, Murphy R, Scott AM, Maraskovsky E, McArthur G, MacGregor D, Sturrock S, ... ... Old LJ, et al. Erratum: Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans (Proceedings of the National Academy of Sciences of the United States of America (July 20, 2004) 101, 29 (10697-10702)) Proceedings of the National Academy of Sciences of the United States of America. 102. DOI: 10.1073/Pnas.0504548102 |
0.351 |
|
| 2004 |
Vaughan HA, Svobodova S, MacGregor D, Sturrock S, Jungbluth AA, Browning J, Davis ID, Parente P, Chen Y, Stockert E, Clair FS, Old LJ, Cebon J. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1. Clinical Cancer Research. 10: 8396-8404. PMID 15623618 DOI: 10.1158/1078-0432.Ccr-04-0809 |
0.436 |
|
| 2004 |
Huarte E, Karbach J, Gnjatic S, Bender A, Jäger D, Arand M, Atanackovic D, Skipper J, Ritter G, Chen YT, Old LJ, Knuth A, Jäger E. HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones. Cancer Immunity. 4: 15. PMID 15600300 |
0.326 |
|
| 2004 |
Campagnolo C, Meyers KJ, Ryan T, Atkinson RC, Chen YT, Scanlan MJ, Ritter G, Old LJ, Batt CA. Real-Time, label-free monitoring of tumor antigen and serum antibody interactions. Journal of Biochemical and Biophysical Methods. 61: 283-98. PMID 15571777 DOI: 10.1016/J.Jbbm.2004.05.006 |
0.429 |
|
| 2004 |
Lee SY, Williamson B, Caballero OL, Chen YT, Scanlan MJ, Ritter G, Jongeneel CV, Simpson AJ, Old LJ. Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer. Cancer Immunity. 4: 13. PMID 15546177 |
0.355 |
|
| 2004 |
Qian F, Gnjatic S, Jäger E, Santiago D, Jungbluth A, Grande C, Schneider S, Keitz B, Driscoll D, Ritter G, Lele S, Sood A, Old LJ, Odunsi K. Th1/Th2 CD4+ T cell responses against NY-ESO-1 in HLA-DPB1*0401/0402 patients with epithelial ovarian cancer. Cancer Immunity. 4: 12. PMID 15521719 |
0.322 |
|
| 2004 |
Shang XY, Chen HS, Zhang HG, Pang XW, Qiao H, Peng JR, Qin LL, Fei R, Mei MH, Leng XS, Gnjatic S, Ritter G, Simpson AJ, Old LJ, Chen WF. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 6946-55. PMID 15501973 DOI: 10.1158/1078-0432.Ccr-04-0502 |
0.393 |
|
| 2004 |
Tammela J, Jungbluth AA, Qian F, Santiago D, Scanlan MJ, Keitz B, Driscoll D, Rodabaugh K, Lele S, Old LJ, Odunsi K. SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer. Cancer Immunity. 4: 10. PMID 15487888 |
0.328 |
|
| 2004 |
Fujita S, Wada H, Jungbluth AA, Sato S, Nakata T, Noguchi Y, Doki Y, Yasui M, Sugita Y, Yasuda T, Yano M, Ono T, Chen YT, Higashiyama M, Gnjatic S, ... Old LJ, et al. NY-ESO-1 expression and immunogenicity in esophageal cancer. Clinical Cancer Research. 10: 6551-6558. PMID 15475443 DOI: 10.1158/1078-0432.Ccr-04-0819 |
0.411 |
|
| 2004 |
Matsuo M, Nagata Y, Sato E, Atanackovic D, Valmori D, Chen YT, Ritter G, Mellman I, Old LJ, Gnjatic S. IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation. Proceedings of the National Academy of Sciences of the United States of America. 101: 14467-72. PMID 15383663 DOI: 10.1073/Pnas.0405947101 |
0.4 |
|
| 2004 |
Held G, Matsuo M, Epel M, Gnjatic S, Ritter G, Lee SY, Tai TY, Cohen CJ, Old LJ, Pfreundschuh M, Reiter Y, Hoogenboom HR, Renner C. Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments. European Journal of Immunology. 34: 2919-2929. PMID 15368308 DOI: 10.1002/Eji.200425297 |
0.424 |
|
| 2004 |
Jackson HM, Dimopoulos N, Chen Q, Luke T, Yee Tai T, Maraskovsky E, Old LJ, Davis ID, Cebon J, Chen W. A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples. Journal of Immunological Methods. 291: 51-62. PMID 15345304 DOI: 10.1016/J.Jim.2004.04.017 |
0.396 |
|
| 2004 |
Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 21: 137-48. PMID 15308095 DOI: 10.1016/J.Immuni.2004.07.017 |
0.331 |
|
| 2004 |
Damasceno LM, Pla I, Chang HJ, Cohen L, Ritter G, Old LJ, Batt CA. An optimized fermentation process for high-level production of a single-chain Fv antibody fragment in Pichia pastoris. Protein Expression and Purification. 37: 18-26. PMID 15294276 DOI: 10.1016/J.Pep.2004.03.019 |
0.335 |
|
| 2004 |
Vaughan HA, St Clair F, Scanlan MJ, Chen YT, Maraskovsky E, Sizeland A, Old LJ, Cebon J. The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning. Cancer Immunity. 4: 5. PMID 15255672 |
0.342 |
|
| 2004 |
Davis ID, Chen W, Jackson H, Parente P, Shackleton M, Hopkins W, Chen Q, Dimopoulos N, Luke T, Murphy R, Scott AM, Maraskovsky E, McArthur G, MacGregor D, Sturrock S, ... ... Old LJ, et al. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proceedings of the National Academy of Sciences of the United States of America. 101: 10697-702. PMID 15252201 DOI: 10.1073/Pnas.0403572101 |
0.431 |
|
| 2004 |
Chen Q, Jackson H, Parente P, Luke T, Rizkalla M, Tai TY, Zhu HC, Mifsud NA, Dimopoulos N, Masterman KA, Hopkins W, Goldie H, Maraskovsky E, Green S, Miloradovic L, ... ... Old LJ, et al. Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant. Proceedings of the National Academy of Sciences of the United States of America. 101: 9363-8. PMID 15197261 DOI: 10.1073/Pnas.0403271101 |
0.437 |
|
| 2004 |
Ayyoub M, Hesdorffer CS, Metthez G, Stevanovic S, Ritter G, Chen Y, Old LJ, Speiser D, Cerottini J, Valmori D. Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells. Journal of Immunology. 172: 7206-7211. PMID 15153546 DOI: 10.4049/Jimmunol.172.11.7206 |
0.436 |
|
| 2004 |
Ayyoub M, Hesdorffer CS, Montes M, Merlo A, Speiser D, Rimoldi D, Cerottini JC, Ritter G, Scanlan M, Old LJ, Valmori D. An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR. The Journal of Clinical Investigation. 113: 1225-33. PMID 15085202 DOI: 10.1172/Jci20667 |
0.482 |
|
| 2004 |
Johns TG, Adams TE, Cochran JR, Hall NE, Hoyne PA, Olsen MJ, Kim YS, Rothacker J, Nice EC, Walker F, Ritter G, Jungbluth AA, Old LJ, Ward CW, Burgess AW, et al. Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor. The Journal of Biological Chemistry. 279: 30375-84. PMID 15075331 DOI: 10.1074/Jbc.M401218200 |
0.326 |
|
| 2004 |
Deckert PM, Bornmann WG, Ritter G, Williams C, Franke J, Keilholz U, Thiel E, Old LJ, Bertino JR, Welt S. Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine. International Journal of Oncology. 24: 1289-1295. PMID 15067353 DOI: 10.3892/Ijo.24.5.1289 |
0.348 |
|
| 2004 |
Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annual Review of Immunology. 22: 329-60. PMID 15032581 DOI: 10.1146/Annurev.Immunol.22.012703.104803 |
0.362 |
|
| 2004 |
Sugita Y, Wada H, Fujita S, Nakata T, Sato S, Noguchi Y, Jungbluth AA, Yamaguchi M, Chen YT, Stockert E, Gnjatic S, Williamson B, Scanlan MJ, Ono T, Sakita I, ... ... Old LJ, et al. NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors. Cancer Research. 64: 2199-204. PMID 15026363 DOI: 10.1158/0008-5472.Can-03-3070 |
0.378 |
|
| 2004 |
Atanackovic D, Altorki NK, Stockert E, Williamson B, Jungbluth AA, Ritter E, Santiago D, Ferrara CA, Matsuo M, Selvakumar A, Dupont B, Chen YT, Hoffman EW, Ritter G, Old LJ, et al. Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients. Journal of Immunology (Baltimore, Md. : 1950). 172: 3289-96. PMID 14978137 DOI: 10.4049/Jimmunol.172.5.3289 |
0.409 |
|
| 2004 |
Wang Y, Liang Z, Yuan Y, Han Y, Liu Y, Liu N, Chen Y, Ritter G, Old LJ, Zhang L. [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery]. National Medical Journal of China. 84: 464-468. DOI: 10.3760/J:Issn:0376-2491.2004.06.010 |
0.379 |
|
| 2004 |
Chen LC, Vural B, Ustuner Z, Saip P, Ozbek U, Gonen M, Old L, Chen Y-, Gure A. Immunoreactivity to SOX-1, -2, -3 and ZIC2 antigens and correlation to survival in small cell lung cancer (SCLC) Journal of Clinical Oncology. 22: 7159-7159. DOI: 10.1200/Jco.2004.22.90140.7159 |
0.425 |
|
| 2004 |
Bender A, Karbach J, Neumann A, Biskamp M, Jäger D, Gnjatic S, Hoffman E, Old L, Knuth A, Jäger E. LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers Cancer Cell International. 4: 1-1. DOI: 10.1186/1475-2867-4-S1-S18 |
0.303 |
|
| 2004 |
Jungbluth A, Busam K, Iversen K, Kolb D, Coplan K, Chen Y, Zhang P, Old L, Nelson P. Expression of cancer testis (CT) antigens in ovary Pathology - Research and Practice. 200: 360-361. DOI: 10.1016/S0344-0338(04)80788-X |
0.366 |
|
| 2004 |
Jungbluth AA, Williams C, Kolb D, Coplan K, Sato E, Ritter G, Old LJ, Scanlan MJ. A34 — Expression of a novel differentiation antigen of the stomach mucosa on a protein level Pathology Research and Practice. 200: 315. DOI: 10.1016/S0344-0338(04)80628-9 |
0.322 |
|
| 2003 |
Sharma P, Gnjatic S, Jungbluth AA, Williamson B, Herr H, Stockert E, Dalbagni G, Donat SM, Reuter VE, Santiago D, Chen YT, Bajorin DF, Old LJ. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer. Cancer Immunity. 3: 19. PMID 14680360 |
0.342 |
|
| 2003 |
Oosterwijk E, Brouwers A, Boerman OC, Larson SM, Old LJ, Mulders P, Divgi CR. Monoclonal antibody therapy of kidney cancer. Cancer Treatment and Research. 116: 199-212. PMID 14650834 DOI: 10.1007/978-1-4615-0451-1_12 |
0.319 |
|
| 2003 |
Chen YT, Alpen B, Ono T, Gure AO, Scanlan MA, Biggs WH, Arden K, Nakayama E, Old LJ. Identification and characterization of mouse SSX genes: a multigene family on the X chromosome with restricted cancer/testis expression. Genomics. 82: 628-36. PMID 14611804 DOI: 10.1016/S0888-7543(03)00183-6 |
0.361 |
|
| 2003 |
Rodolfo M, Luksch R, Stockert E, Chen YT, Collini P, Ranzani T, Lombardo C, Dalerba P, Rivoltini L, Arienti F, Fossati-Bellani F, Old LJ, Parmiani G, Castelli C. Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen. Cancer Research. 63: 6948-55. PMID 14583496 |
0.398 |
|
| 2003 |
Ayyoub M, Brehm M, Metthez G, Talbot S, Dutoit V, Taub RN, Keohan ML, Gure AO, Chen YT, Williamson B, Jungbluth AA, Old LJ, Hesdorffer CS, Valmori D. SSX antigens as tumor vaccine targets in human sarcoma. Cancer Immunity. 3: 13. PMID 14533943 |
0.324 |
|
| 2003 |
Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, ... ... Old LJ, et al. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Cancer Research. 63: 6076-83. PMID 14522938 |
0.36 |
|
| 2003 |
Tajima K, Obata Y, Tamaki H, Yoshida M, Chen YT, Scanlan MJ, Old LJ, Kuwano H, Takahashi T, Takahashi T, Mitsudomi T. Expression of cancer/testis (CT) antigens in lung cancer. Lung Cancer (Amsterdam, Netherlands). 42: 23-33. PMID 14512184 DOI: 10.1016/S0169-5002(03)00244-7 |
0.401 |
|
| 2003 |
Atanackovic D, Matsuo M, Ritter E, Mazzara G, Ritter G, Jäger E, Knuth A, Old LJ, Gnjatic S. Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC. Journal of Immunological Methods. 278: 57-66. PMID 12957396 DOI: 10.1016/S0022-1759(03)00209-6 |
0.418 |
|
| 2003 |
Oosterwijk E, Divgi CR, Brouwers A, Boerman OC, Larson SM, Mulders P, Old LJ. Monoclonal antibody-based therapy for renal cell carcinoma Urologic Clinics of North America. 30: 623-631. PMID 12953760 DOI: 10.1016/S0094-0143(03)00028-4 |
0.316 |
|
| 2003 |
Nishikawa H, Kato T, Tanida K, Hiasa A, Tawara I, Ikeda H, Ikarashi Y, Wakasugi H, Kronenberg M, Nakayama T, Taniguchi M, Kuribayashi K, Old LJ, Shiku H. CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proceedings of the National Academy of Sciences of the United States of America. 100: 10902-10906. PMID 12947044 DOI: 10.1073/Pnas.1834479100 |
0.425 |
|
| 2003 |
Gnjatic S, Atanackovic D, Jäger E, Matsuo M, Selvakumar A, Altorki NK, Maki RG, Dupont B, Ritter G, Chen YT, Knuth A, Old LJ. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proceedings of the National Academy of Sciences of the United States of America. 100: 8862-7. PMID 12853579 DOI: 10.1073/Pnas.1133324100 |
0.431 |
|
| 2003 |
Mischo A, Wadle A, Wätzig K, Jäger D, Stockert E, Santiago D, Ritter G, Regitz E, Jäger E, Knuth A, Old L, Pfreundschuh M, Renner C. Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients. Cancer Immunity. 3: 5. PMID 12828452 |
0.386 |
|
| 2003 |
Lee SY, Obata Y, Yoshida M, Stockert E, Williamson B, Jungbluth AA, Chen YT, Old LJ, Scanlan MJ. Immunomic analysis of human sarcoma. Proceedings of the National Academy of Sciences of the United States of America. 100: 2651-6. PMID 12601173 DOI: 10.1073/Pnas.0437972100 |
0.469 |
|
| 2003 |
Gnjatic S, Atanackovic D, Matsuo M, Jäger E, Lee SY, Valmori D, Chen YT, Ritter G, Knuth A, Old LJ. Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs Journal of Immunology. 170: 1191-1196. PMID 12538675 DOI: 10.4049/Jimmunol.170.3.1191 |
0.401 |
|
| 2003 |
Jungbluth AA, Stockert E, Huang HJ, Collins VP, Coplan K, Iversen K, Kolb D, Johns TJ, Scott AM, Gullick WJ, Ritter G, Cohen L, Scanlan MJ, Cavenee WK, Old LJ, et al. A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor. Proceedings of the National Academy of Sciences of the United States of America. 100: 639-44. PMID 12515857 DOI: 10.1073/Pnas.232686499 |
0.402 |
|
| 2002 |
Jäger E, Karbach J, Gnjatic S, Jäger D, Maeurer M, Atmaca A, Arand M, Skipper J, Stockert E, Chen YT, Old LJ, Knuth A. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. Cancer Immunity. 2: 12. PMID 12747757 |
0.325 |
|
| 2002 |
Jäger D, Stockert E, Karbach J, Herrlinger K, Atmaca A, Arand M, Chen YT, Gnjatic S, Old LJ, Knuth A, Jäger E. Urine antibody against human cancer antigen NY-ESO-1. Cancer Immunity. 2: 10. PMID 12747755 |
0.327 |
|
| 2002 |
Koroleva EP, Lagarkova MA, Mesheryakov AA, Scanlan MJ, Old LJ, Nedospasov SA, Kuprash DV. Serological identification of antigens associated with renal cell carcinoma. Russian Journal of Immunology : Rji : Official Journal of Russian Society of Immunology. 7: 229-38. PMID 12674932 |
0.302 |
|
| 2002 |
Dutoit V, Taub RN, Papadopoulos KP, Talbot S, Keohan ML, Brehm M, Gnjatic S, Harris PE, Bisikirska B, Guillaume P, Cerottini JC, Hesdorffer CS, Old LJ, Valmori D. Multiepitope CD8 + T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting Journal of Clinical Investigation. 110: 1813-1822. PMID 12488431 DOI: 10.1172/Jci16428 |
0.383 |
|
| 2002 |
Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunological Reviews. 188: 22-32. PMID 12445278 DOI: 10.1034/j.1600-065x.2002.18803.x |
0.358 |
|
| 2002 |
Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunology. 3: 991-8. PMID 12407406 DOI: 10.1038/Ni1102-991 |
0.368 |
|
| 2002 |
Alpen B, Güre AO, Scanlan MJ, Old LJ, Chen YT. A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved. Gene. 297: 141-9. PMID 12384295 DOI: 10.1016/S0378-1119(02)00879-X |
0.353 |
|
| 2002 |
Güre AO, Wei IJ, Old LJ, Chen Y. The SSX gene family: characterization of 9 complete genes International Journal of Cancer. 101: 448-453. PMID 12216073 DOI: 10.1002/Ijc.10634 |
0.398 |
|
| 2002 |
Gnjatic S, Jäger E, Chen W, Altorki NK, Matsuo M, Lee SY, Chen Q, Nagata Y, Atanackovic D, Chen YT, Ritter G, Cebon J, Knuth A, Old LJ. CD8 + T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients Proceedings of the National Academy of Sciences of the United States of America. 99: 11813-11818. PMID 12186971 DOI: 10.1073/Pnas.142417699 |
0.464 |
|
| 2002 |
Forti S, Scanlan MJ, Invernizzi A, Castiglioni F, Pupa S, Agresti R, Fontanelli R, Morelli D, Old LJ, Pupa SM, Ménard S. Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum. Breast Cancer Research and Treatment. 73: 245-56. PMID 12160330 DOI: 10.1023/A:1015854415746 |
0.404 |
|
| 2002 |
Nagata Y, Ono S, Matsuo M, Gnjatic S, Valmori D, Ritter G, Garrett W, Old LJ, Mellman I. Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations. Proceedings of the National Academy of Sciences of the United States of America. 99: 10629-34. PMID 12138174 DOI: 10.1073/Pnas.112331099 |
0.405 |
|
| 2002 |
Scanlan MJ, Welt S, Gordon CM, Chen YT, Gure AO, Stockert E, Jungbluth AA, Ritter G, Jäger D, Jäger E, Knuth A, Old LJ. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Research. 62: 4041-7. PMID 12124339 |
0.33 |
|
| 2002 |
Jungbluth AA, Chen Y, Busam KJ, Coplan K, Kolb D, Iversen K, Williamson B, Landeghem FKHv, Stockert E, Old LJ. CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues International Journal of Cancer. 99: 839-845. PMID 12115486 DOI: 10.1002/Ijc.10416 |
0.361 |
|
| 2002 |
Antonescu CR, Busam KJ, Iversen K, Kolb D, Coplan K, Spagnoli GC, Ladanyi M, Old LJ, Jungbluth AA. MAGE antigen expression in monophasic and biphasic synovial sarcoma Human Pathology. 33: 225-229. PMID 11957149 DOI: 10.1053/Hupa.2002.31295 |
0.43 |
|
| 2002 |
Scanlan MJ, Gordon CM, Williamson B, Lee SY, Chen YT, Stockert E, Jungbluth A, Ritter G, Jäger D, Jäger E, Knuth A, Old LJ. Identification of cancer/testis genes by database mining and mRNA expression analysis. International Journal of Cancer. Journal International Du Cancer. 98: 485-92. PMID 11920606 DOI: 10.1002/Ijc.10276 |
0.33 |
|
| 2002 |
Johns TG, Stockert E, Ritter G, Jungbluth AA, Huang HJ, Cavenee WK, Smyth FE, Hall CM, Watson N, Nice EC, Gullick WJ, Old LJ, Burgess AW, Scott AM. Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene. International Journal of Cancer. Journal International Du Cancer. 98: 398-408. PMID 11920591 DOI: 10.1002/Ijc.10189 |
0.374 |
|
| 2002 |
Ikeda H, Old LJ, Schreiber RD. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine & Growth Factor Reviews. 13: 95-109. PMID 11900986 DOI: 10.1016/S1359-6101(01)00038-7 |
0.324 |
|
| 2001 |
Nishikawa H, Tanida K, Ikeda H, Sakakura M, Miyahara Y, Aota T, Mukai K, Watanabe M, Kuribayashi K, Old LJ, Shiku H. Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity Proceedings of the National Academy of Sciences of the United States of America. 98: 14571-14576. PMID 11724951 DOI: 10.1073/Pnas.251547298 |
0.445 |
|
| 2001 |
Jungbluth AA, Antonescu CR, Busam KJ, Iversen K, Kolb D, Coplan K, Chen YT, Stockert E, Ladanyi M, Old LJ. Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. International Journal of Cancer. 94: 252-256. PMID 11668506 DOI: 10.1002/Ijc.1451 |
0.404 |
|
| 2001 |
Scott AM, Lee FT, Hopkins W, Cebon JS, Wheatley JM, Liu Z, Smyth FE, Murone C, Sturrock S, MacGregor D, Hanai N, Inoue K, Yamasaki M, Brechbiel MW, Davis ID, ... ... Old LJ, et al. Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 3976-87. PMID 11579119 DOI: 10.1200/Jco.2001.19.19.3976 |
0.348 |
|
| 2001 |
Jungbluth AA, Chen Y, Stockert E, Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ. Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues International Journal of Cancer. 92: 856-860. PMID 11351307 DOI: 10.1002/Ijc.1282 |
0.416 |
|
| 2001 |
Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 410: 1107-11. PMID 11323675 DOI: 10.1038/35074122 |
0.337 |
|
| 2001 |
Tanswell P, Garin-Chesa P, Rettig WJ, Welt S, Divgi CR, Casper ES, Finn RD, Larson SM, Old LJ, Scott AM. Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients. British Journal of Clinical Pharmacology. 51: 177-180. PMID 11259992 DOI: 10.1111/J.1365-2125.2001.01335.X |
0.37 |
|
| 2001 |
Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N, Aoe M, Nakamura S, Higashi T, Hiraki A, Wada H, Kumon H, Old LJ, Nakayama E. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proceedings of the National Academy of Sciences of the United States of America. 98: 3282-3287. PMID 11248070 DOI: 10.1073/Pnas.041625098 |
0.401 |
|
| 2001 |
Jungbluth AA, King R, Fisher DE, Iversen K, Coplan K, Kolb D, Williamson B, Chen Y, Stockert E, Old LJ, Busam KJ. Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas. Applied Immunohistochemistry & Molecular Morphology. 9: 29-34. DOI: 10.1097/00022744-200103000-00007 |
0.363 |
|
| 2000 |
Ono T, Sato S, Kimura N, Tanaka M, Shibuya A, Old LJ, Nakayama E. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: Identification of a cancer/testis antigen International Journal of Cancer. 88: 845-851. PMID 11093803 DOI: 10.1002/1097-0215(20001215)88:6<845::Aid-Ijc1>3.0.Co;2-N |
0.424 |
|
| 2000 |
Jäger E, Gnjatic S, Nagata Y, Stockert E, Jäger D, Karbach J, Neumann A, Rieckenberg J, Chen Y, Ritter G, Hoffman E, Arand M, Old LJ, Knuth A. Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proceedings of the National Academy of Sciences of the United States of America. 97: 12198-12203. PMID 11027314 DOI: 10.1073/Pnas.220413497 |
0.476 |
|
| 2000 |
Hanson HL, Donermeyer DL, Ikeda H, White JM, Shankaran V, Old LJ, Shiku H, Schreiber RD, Allen PM. Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity. 13: 265-76. PMID 10981969 DOI: 10.1016/S1074-7613(00)00026-1 |
0.394 |
|
| 2000 |
Obata Y, Takahashi T, Sakamoto J, Tamaki H, Tominaga S, Hamajima N, Chen YT, Old LJ. Serex analysis of gastric cancer antigens Cancer Chemotherapy and Pharmacology. 46: S37-S42. PMID 10950146 DOI: 10.1007/Pl00014048 |
0.398 |
|
| 2000 |
Deckert PM, Jungbluth A, Montalto N, Clark MA, Finn RD, Williams C, Richards EC, Panageas KS, Old LJ, Welt S. Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts. International Journal of Cancer. Journal International Du Cancer. 87: 382-90. PMID 10897044 DOI: 10.1002/1097-0215(20000801)87:3<382::Aid-Ijc12>3.0.Co;2-P |
0.433 |
|
| 2000 |
Chen J, Dunbar PR, Gileadi U, Jäger E, Gnjatic S, Nagata Y, Stockert E, Panicali DL, Chen Y, Knuth A, Old LJ, Cerundolo V. Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL Journal of Immunology. 165: 948-955. PMID 10878370 DOI: 10.4049/Jimmunol.165.2.948 |
0.358 |
|
| 2000 |
Rader C, Ritter G, Nathan S, Elia M, Gout I, Jungbluth AA, Cohen LS, Welt S, Old LJ, Barbas CF. The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. The Journal of Biological Chemistry. 275: 13668-76. PMID 10788485 DOI: 10.1074/Jbc.275.18.13668 |
0.395 |
|
| 2000 |
Busam KJ, Iversen K, Berwick M, Spagnoli GC, Old LJ, Jungbluth AA. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters. Modern Pathology. 13: 459-465. PMID 10786815 DOI: 10.1038/Modpathol.3880078 |
0.399 |
|
| 2000 |
Jungbluth AA, Iversen K, Coplan K, Kolb D, Stockert E, Chen Y, Old LJ, Busam K. T311—An Anti-Tyrosinase Monoclonal Antibody for the Detection of Melanocytic Lesions in Paraffin Embedded Tissues Pathology Research and Practice. 196: 235-242. PMID 10782467 DOI: 10.1016/S0344-0338(00)80072-2 |
0.384 |
|
| 2000 |
Jäger E, Nagata Y, Gnjatic S, Wada H, Stockert E, Karbach J, Dunbar PR, Lee SY, Jungbluth A, Jäger D, Arand M, Ritter G, Cerundolo V, Dupont B, Chen YT, ... Old LJ, et al. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proceedings of the National Academy of Sciences of the United States of America. 97: 4760-5. PMID 10781081 DOI: 10.1073/Pnas.97.9.4760 |
0.462 |
|
| 2000 |
Güre AO, Stockert E, Scanlan MJ, Keresztes RS, Jäger D, Altorki NK, Old LJ, Chen YT. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 97: 4198-203. PMID 10760287 DOI: 10.1073/Pnas.97.8.4198 |
0.41 |
|
| 2000 |
Scanlan MJ, Altorki NK, Gure AO, Williamson B, Jungbluth A, Chen YT, Old LJ. Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Letters. 150: 155-64. PMID 10704737 DOI: 10.1016/S0304-3835(99)00385-7 |
0.366 |
|
| 2000 |
Güre AO, Stockert E, Arden KC, Boyer AD, Viars CS, Scanlan MJ, Old LJ, Chen YT. CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. International Journal of Cancer. 85: 726-32. PMID 10699956 DOI: 10.1002/(Sici)1097-0215(20000301)85:5<726::Aid-Ijc21>3.0.Co;2-F |
0.374 |
|
| 2000 |
Jungbluth AA, Busam KJ, Kolb D, Iversen K, Coplan K, Chen Y, Spagnoli GC, Old LJ. Expression of MAGE-antigens in normal tissues and cancer. International Journal of Cancer. 85: 460-465. PMID 10699915 DOI: 10.1002/(Sici)1097-0215(20000215)85:4<460::Aid-Ijc3>3.0.Co;2-N |
0.443 |
|
| 2000 |
Jäger E, Jäger D, Karbach J, Chen Y, Ritter G, Nagata Y, Gnjatic S, Stockert E, Arand M, Old LJ, Knuth A. Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma Journal of Experimental Medicine. 191: 625-630. PMID 10684854 DOI: 10.1084/Jem.191.4.625 |
0.44 |
|
| 1999 |
Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. Journal of Biological Chemistry. 274: 36505-36512. PMID 10593948 DOI: 10.1074/Jbc.274.51.36505 |
0.359 |
|
| 1999 |
Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jäger D, Jäger E, Knuth A, Chen YT, Old LJ. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. International Journal of Cancer. 83: 456-64. PMID 10508479 DOI: 10.1002/(Sici)1097-0215(19991112)83:4<456::Aid-Ijc4>3.0.Co;2-5 |
0.484 |
|
| 1999 |
Jäger E, Stockert E, Zidianakis Z, Chen Y, Karbach J, Jäger D, Arand M, Ritter G, Old LJ, Knuth A. Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. International Journal of Cancer. 84: 506-510. PMID 10502728 DOI: 10.1002/(Sici)1097-0215(19991022)84:5<506::Aid-Ijc10>3.0.Co;2-6 |
0.443 |
|
| 1999 |
Jungbluth AA, Iversen K, Coplan K, Williamson B, Chen Y, Stockert E, Old LJ, Busam KJ. Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis. Virchows Archiv. 434: 429-435. PMID 10389626 DOI: 10.1007/S004280050362 |
0.35 |
|
| 1999 |
Scanlan MJ, Williamson B, Jungbluth A, Stockert E, Arden KC, Viars CS, Gure AO, Gordan JD, Chen YT, Old LJ. Isoforms of the human PDZ-73 protein exhibit differential tissue expression. Biochimica Et Biophysica Acta. 1445: 39-52. PMID 10209257 DOI: 10.1016/S0167-4781(99)00033-0 |
0.349 |
|
| 1999 |
Jäger E, Stockert E, Zidianakis Z, Chen Y, Karbach J, Jäger D, Ritter G, Old LJ, Knuth A. Humoral immune responses of cancer patients against ‘Cancer — Testis’ antigen NY-ESO-1: correlation with clinical events European Journal of Cancer. 35. DOI: 10.1016/S0959-8049(99)81848-6 |
0.361 |
|
| 1999 |
Obata Y, Takahashi T, Tamaki H, Tominaga S, Murai H, Iwase T, Iwata H, Mizutani M, Chen YT, Old LJ, Miura S. Identification of cancer antigens in breast cancer by the SEREX expression cloning method Breast Cancer. 6: 305-311. DOI: 10.1007/Bf02966445 |
0.424 |
|
| 1999 |
Dullenkopf W, Ritter G, Fortunato SR, Old LJ, Schmidt RR. Synthesis of a Structurally Defined Antigen–Immunostimulant Combination for Use in Cancer Vaccines Chemistry: a European Journal. 5: 2432-2438. DOI: 10.1002/(Sici)1521-3765(19990802)5:8<2432::Aid-Chem2432>3.0.Co;2-5 |
0.406 |
|
| 1998 |
Noguchi Y, Wada H, Marino MW, Old LJ. Regulation of IFN‐γ production in granulocyte‐macrophage colony‐stimulating factor‐deficient mice European Journal of Immunology. 28: 3980-3988. PMID 9862334 DOI: 10.1002/(Sici)1521-4141(199812)28:12<3980::Aid-Immu3980>3.0.Co;2-D |
0.31 |
|
| 1998 |
Sahin U, Türeci Ö, Chen Y, Seitz G, Villena-Heinsen C, Old LJ, Pfreundschuh M. Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies International Journal of Cancer. 78: 387-389. PMID 9766577 DOI: 10.1002/(Sici)1097-0215(19981029)78:3<387::Aid-Ijc22>3.0.Co;2-2 |
0.344 |
|
| 1998 |
Busam KJ, Chen Y, Old LJ, Stockert E, Iversen K, Coplan KA, Rosai J, Barnhill RL, Jungbluth AA. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. The American Journal of Surgical Pathology. 22: 976-982. PMID 9706977 DOI: 10.1097/00000478-199808000-00007 |
0.368 |
|
| 1998 |
Türeci Ö, Chen Y, Sahin U, Güre AO, Zwick C, Villena C, Tsang S, Seitz G, Old LJ, Pfreundschuh M. Expression of SSX genes in human tumors International Journal of Cancer. 77: 19-23. PMID 9639388 DOI: 10.1002/(Sici)1097-0215(19980703)77:1<19::Aid-Ijc4>3.0.Co;2-2 |
0.409 |
|
| 1998 |
Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proceedings of the National Academy of Sciences of the United States of America. 95: 7556-61. PMID 9636188 DOI: 10.1073/Pnas.95.13.7556 |
0.318 |
|
| 1998 |
Chen Y, Güre AO, Tsang S, Stockert E, Jäger E, Knuth A, Old LJ. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library Proceedings of the National Academy of Sciences of the United States of America. 95: 6919-6923. PMID 9618514 DOI: 10.1073/Pnas.95.12.6919 |
0.41 |
|
| 1998 |
Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Türeci O, Sahin U, Pfreundschuh M, Old LJ. Characterization of human colon cancer antigens recognized by autologous antibodies. International Journal of Cancer. 76: 652-8. PMID 9610721 DOI: 10.1002/(Sici)1097-0215(19980529)76:5<652::Aid-Ijc7>3.0.Co;2-P |
0.465 |
|
| 1998 |
Jungbluth AA, Busam KJ, Gerald WL, Stockert E, Coplan KA, Iversen K, MacGregor DP, Old LJ, Chen Y. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. The American Journal of Surgical Pathology. 22: 595-602. PMID 9591730 DOI: 10.1097/00000478-199805000-00011 |
0.308 |
|
| 1998 |
Stockert E, Jäger E, Chen YT, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A, Old LJ. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. The Journal of Experimental Medicine. 187: 1349-54. PMID 9547346 DOI: 10.1084/Jem.187.8.1349 |
0.461 |
|
| 1998 |
Old LJ, Chen Y. New paths in human cancer serology. Journal of Experimental Medicine. 187: 1163-1167. PMID 9547328 DOI: 10.1084/Jem.187.8.1163 |
0.344 |
|
| 1998 |
Moritz RL, Ritter G, Catimel B, Cohen LS, Welt S, Old LJ, Burgess AW, Nice EC, Simpson RJ. Micro-sequencing strategies for the human A33 antigen, a novel surface glycoprotein of human gastrointestinal epithelium. Journal of Chromatography. A. 798: 91-101. PMID 9542130 DOI: 10.1016/S0021-9673(97)01031-5 |
0.367 |
|
| 1998 |
Barendswaard EC, Scott AM, Divgi CR, Williams C, Coplan K, Riedel E, Yao TJ, Gansow OA, Finn RD, Larson SM, Old LJ, Welt S. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice. International Journal of Oncology. 12: 45-53. PMID 9454885 DOI: 10.3892/Ijo.12.1.45 |
0.404 |
|
| 1998 |
Jäger E, Chen Y, Drijfhout JW, Karbach J, Ringhoffer M, Jäger D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A. Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes Journal of Experimental Medicine. 187: 265-270. PMID 9432985 DOI: 10.1084/Jem.187.2.265 |
0.466 |
|
| 1997 |
Chen Y-, Boyer AD, Viars CS, Tsang S, Old LJ, Arden KC. Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1 to human chromosome Xq28 Cytogenetic and Genome Research. 79: 237-240. PMID 9605863 DOI: 10.1159/000134734 |
0.37 |
|
| 1997 |
Boon T, Old L. Cancer Tumor antigens. Current Opinion in Immunology. 9: 681-683. PMID 9438857 DOI: 10.1016/S0952-7915(97)80049-0 |
0.409 |
|
| 1997 |
Gure AO, Türeci O, Sahin U, Tsang S, Scanlan MJ, Jäger E, Knuth A, Pfreundschuh M, Old LJ, Chen YT. SSX: a multigene family with several members transcribed in normal testis and human cancer. International Journal of Cancer. 72: 965-71. PMID 9378559 DOI: 10.1002/(Sici)1097-0215(19970917)72:6<965::Aid-Ijc8>3.0.Co;2-N |
0.386 |
|
| 1997 |
Wada H, Noguchi Y, Marino MW, Dunn AR, Old LJ. T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 94: 12557-61. PMID 9356488 DOI: 10.1073/Pnas.94.23.12557 |
0.36 |
|
| 1997 |
Ritter G, Cohen LS, Nice EC, Catimel B, Burgess AW, Moritz RL, Ji H, Heath JK, White SJ, Welt S, Old LJ, Simpson RJ. Characterization of posttranslational modifications of human A33 antigen, a novel palmitoylated surface glycoprotein of human gastrointestinal epithelium. Biochemical and Biophysical Research Communications. 236: 682-6. PMID 9245713 DOI: 10.1006/Bbrc.1997.6966 |
0.351 |
|
| 1997 |
Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ. Characterization of tumor necrosis factor-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 94: 8093-8. PMID 9223320 DOI: 10.1073/Pnas.94.15.8093 |
0.314 |
|
| 1997 |
Ji H, Moritz RL, Reid GE, Ritter G, Catimel B, Nice E, Heath JK, White SJ, Welt S, Old LJ, Burgess AW, Simpson RJ. Electrophoretic analysis of the novel antigen for the gastrointestinal-specific monoclonal antibody, A33. Electrophoresis. 18: 614-21. PMID 9150949 DOI: 10.1002/Elps.1150180345 |
0.415 |
|
| 1997 |
Niedermeyer J, Scanlan MJ, Garin-Chesa P, Daiber C, Fiebig HH, Old LJ, Rettig WJ, Schnapp A. Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers. International Journal of Cancer. 71: 383-9. PMID 9139873 DOI: 10.1002/(Sici)1097-0215(19970502)71:3<383::Aid-Ijc14>3.0.Co;2-H |
0.383 |
|
| 1997 |
Chen YT, Scanlan MJ, Sahin U, Türeci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proceedings of the National Academy of Sciences of the United States of America. 94: 1914-8. PMID 9050879 DOI: 10.1073/Pnas.94.5.1914 |
0.463 |
|
| 1997 |
Heath JK, White SJ, Johnstone CN, Catimel B, Simpson RJ, Moritz RL, Tu GF, Ji H, Whitehead RH, Groenen LC, Scott AM, Ritter G, Cohen L, Welt S, Old LJ, et al. The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proceedings of the National Academy of Sciences of the United States of America. 94: 469-74. PMID 9012807 DOI: 10.1073/Pnas.94.2.469 |
0.386 |
|
| 1997 |
Old LJ, Welt S, Ritter G, Simpson RJ, Nice E, Moritz RL, Catimel B, Ji H, Burgess A, Heath J, White S, Johnston C. Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides Biofutur. 1997: 46. DOI: 10.1016/S0294-3506(99)80328-7 |
0.354 |
|
| 1996 |
GarinChesa P, Sakamoto J, Welt S, Real F, Rettig W, Old L. Organ-specific expression of the colon cancer antigen A33, a cell surface target for antibody-based therapy. International Journal of Oncology. 9: 465-471. PMID 21541536 DOI: 10.3892/Ijo.9.3.465 |
0.376 |
|
| 1996 |
Chen YT, Stockert E, Jungbluth A, Tsang S, Coplan KA, Scanlan MJ, Old LJ. Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proceedings of the National Academy of Sciences of the United States of America. 93: 5915-9. PMID 8650193 DOI: 10.1073/Pnas.93.12.5915 |
0.406 |
|
| 1996 |
Ritter G, Fortunato SR, Cohen L, Noguchi Y, Bernard EM, Stockert E, Old LJ. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Campylobacter jejuni International Journal of Cancer. 66: 184-190. PMID 8603809 DOI: 10.1002/(Sici)1097-0215(19960410)66:2<184::Aid-Ijc8>3.0.Co;2-Z |
0.411 |
|
| 1995 |
Kitamura K, Livingston PO, Fortunato SR, Stockert E, Helling F, Ritter G, Oettgen HF, Old LJ. Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine. Proceedings of the National Academy of Sciences of the United States of America. 92: 2805-2809. PMID 7708728 DOI: 10.1073/Pnas.92.7.2805 |
0.407 |
|
| 1995 |
Chen Y, Stockert E, Tsang S, Coplan KA, Old LJ. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development Proceedings of the National Academy of Sciences of the United States of America. 92: 8125-8129. PMID 7667256 DOI: 10.1073/Pnas.92.18.8125 |
0.419 |
|
| 1995 |
Ritter G, Ritter-Boosfeld E, Adluri R, Calves M, Ren S, Yu RK, Oettgen HF, Old LJ, Livingston PO. Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma. International Journal of Cancer. 62: 668-672. PMID 7558412 DOI: 10.1002/Ijc.2910620604 |
0.328 |
|
| 1995 |
Brenner PC, Rettig WJ, Sanz-Moncasi MP, Reuter V, Aprikian A, Old LJ, Fair WR, Garin-Chesa P. TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49. The Journal of Urology. 153: 1575-9. PMID 7536270 DOI: 10.1016/S0022-5347(01)67465-2 |
0.335 |
|
| 1994 |
Chen YT, Stockert E, Chen Y, Garin-Chesa P, Rettig WJ, van der Bruggen P, Boon T, Old LJ. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America. 91: 1004-8. PMID 8302824 DOI: 10.1073/Pnas.91.3.1004 |
0.416 |
|
| 1994 |
Noguchi Y, Chen Y, Old LJ. A mouse mutant p53 product recognized by CD4+ and CD8+ T cells. Proceedings of the National Academy of Sciences of the United States of America. 91: 3171-3175. PMID 7909159 DOI: 10.1073/Pnas.91.8.3171 |
0.346 |
|
| 1994 |
Dighe AS, Richards E, Old LJ, Schreiber RD. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity. 1: 447-56. PMID 7895156 DOI: 10.1016/1074-7613(94)90087-6 |
0.363 |
|
| 1994 |
Kitamura K, Stockert E, Garin-Chesa P, Welt S, Lloyd KO, Armour KL, Wallace TP, Harris WJ, Carr FJ, Old LJ. Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants. Proceedings of the National Academy of Sciences of the United States of America. 91: 12957-61. PMID 7809154 DOI: 10.1073/Pnas.91.26.12957 |
0.33 |
|
| 1994 |
Caron P, Jurcic J, Scott A, Finn R, Divgi C, Graham M, Jureidini I, Sgouros G, Tyson D, Old L. A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity Blood. 83: 1760-1768. DOI: 10.1182/Blood.V83.7.1760.1760 |
0.323 |
|
| 1993 |
Czuczman MS, Straus DJ, Divgi CR, Graham M, Garin-Chesa P, Finn R, Myers J, Old LJ, Larson SM, Scheinberg DA. Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-hodgkin's lymphoma Journal of Clinical Oncology. 11: 2021-2029. PMID 8410126 DOI: 10.1200/Jco.1993.11.10.2021 |
0.32 |
|
| 1992 |
Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Jaffe EA, Old LJ. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proceedings of the National Academy of Sciences of the United States of America. 89: 10832-6. PMID 1438285 DOI: 10.1073/Pnas.89.22.10832 |
0.428 |
|
| 1992 |
Old LJ. Tumor immunology: the first century. Current Opinion in Immunology. 4: 603-607. PMID 1418726 DOI: 10.1016/0952-7915(92)90034-C |
0.303 |
|
| 1991 |
Ritter G, Boosfeld E, Adluri R, Calves M, Oettgen HF, Old LJ, Livingston P. Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma. International Journal of Cancer. 48: 379-385. PMID 2040532 DOI: 10.1002/Ijc.2910480312 |
0.424 |
|
| 1991 |
Oosterwijk E, Kalisiak A, Wakka JC, Scheinberg DA, Old LJ. Monoclonal antibodies against Galα1-4Galβ1-4Glc (P(k), CD77) produced with a synthetic glycoconjugate as immunogen: Reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors International Journal of Cancer. 48: 848-854. PMID 1860732 DOI: 10.1002/Ijc.2910480610 |
0.398 |
|
| 1991 |
Kalisiak A, Oosterwijk E, Minniti JG, Old LJ, Scheinberg DA. A monoclonal antibody for terminal β-galactose. Use in analysis of glycosphingolipids Glycoconjugate Journal. 8: 55-62. PMID 1726670 DOI: 10.1007/Bf00731643 |
0.352 |
|
| 1990 |
Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proceedings of the National Academy of Sciences of the United States of America. 87: 7235-7239. PMID 2402505 DOI: 10.1073/Pnas.87.18.7235 |
0.346 |
|
| 1990 |
Chen YT, Rettig WJ, Yenamandra AK, Kozak CA, Chaganti RS, Posner JB, Old LJ. Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. Proceedings of the National Academy of Sciences of the United States of America. 87: 3077-81. PMID 2326268 DOI: 10.1073/Pnas.87.8.3077 |
0.318 |
|
| 1990 |
Yamaguchi H, Furukawa K, Fortunato SR, Livingston PO, Lloyd KO, Oettgen HF, Old LJ. Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient. Proceedings of the National Academy of Sciences of the United States of America. 87: 3333-3337. PMID 2159145 DOI: 10.1073/Pnas.87.9.3333 |
0.452 |
|
| 1990 |
Ritter G, Boosfeld E, Calves MJ, Oettgen HF, Old LJ, Livingston PO. Antibody Response to Immunization with Purified GD3 Ganglioside and GD3 Derivatives (Lactones, Amide and Gangliosidol) in the Mouse Immunobiology. 182: 32-43. PMID 2098322 DOI: 10.1016/S0171-2985(11)80581-4 |
0.412 |
|
| 1989 |
Jennings MT, Jennings VDL, Asadourian LLH, Ebrahim SAD, Klein CE, Old LJ. Antigenic phenotypes of cultured malignant astrocytomas: identification of lineage-consistent, lineage-independent and putative tumor-restricted antigenic expression. Journal of the Neurological Sciences. 89: 79-92. PMID 2926444 DOI: 10.1016/0022-510X(89)90008-7 |
0.46 |
|
| 1989 |
Jennings MT, Jennings VD, Asadourian LL, Rosenblum M, Albino AP, Cairncross JG, Old LJ. Five novel cell surface antigens of CNS neoplasms. Journal of the Neurological Sciences. 89: 63-78. PMID 2926443 DOI: 10.1016/0022-510X(89)90007-5 |
0.456 |
|
| 1989 |
Xu M, Real FX, Welt S, Schüssler MH, Oettgen HF, Old LJ. Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer. International Journal of Cancer. 44: 985-989. PMID 2481651 DOI: 10.1002/Ijc.2910440607 |
0.377 |
|
| 1988 |
Srivastava PK, Kozak CA, Old LJ. Chromosomal assignment of the gene encoding the mouse tumor rejection antigen gp96. Immunogenetics. 28: 205-207. PMID 3410508 DOI: 10.1007/Bf00375860 |
0.347 |
|
| 1988 |
Obata Y, Stockert E, Chen Y, Takahashi T, Old LJ. Influence of 5' flanking sequences on TL and H-2 expression in transfected L cells. Proceedings of the National Academy of Sciences of the United States of America. 85: 3541-3545. PMID 3368465 DOI: 10.1073/Pnas.85.10.3541 |
0.368 |
|
| 1988 |
Cote RJ, Rosen PP, Hakes TB, Sedira M, Bazinet M, Kinne DW, Old LJ, Osborne MP. Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. The American Journal of Surgical Pathology. 12: 333-40. PMID 3364618 DOI: 10.1097/00000478-198805000-00001 |
0.347 |
|
| 1988 |
Rettig WJ, Grzeschik KH, Yenamandra AK, Garcia E, Old LJ. Definition of selectable cell surface markers for human chromosomes and chromosome segments in rodent-human hybrids. Somatic Cell and Molecular Genetics. 14: 223-231. PMID 3163425 DOI: 10.1007/Bf01534583 |
0.331 |
|
| 1988 |
Srivastava PK, Old LJ. Individually distinct transplantation antigens of chemically induced mouse tumors Immunology Today. 9: 78-83. PMID 3076762 DOI: 10.1016/0167-5699(88)91269-8 |
0.407 |
|
| 1988 |
Schrump DS, Furukawa K, Yamaguchi H, Lloyd KO, Old LJ. Recognition of galactosylgloboside by monoclonal antibodies derived from patients with primary lung cancer Proceedings of the National Academy of Sciences of the United States of America. 85: 4441-4445. PMID 2837767 DOI: 10.1073/Pnas.85.12.4441 |
0.432 |
|
| 1988 |
Thomson TM, Rettig WJ, Chesa PG, Green SH, Mena AC, Old LJ. Expression of human nerve growth factor receptor on cells derived from all three germ layers. Experimental Cell Research. 174: 533-9. PMID 2828087 DOI: 10.1016/0014-4827(88)90323-0 |
0.33 |
|
| 1988 |
Welt S, Yin BWT, Furukawa K, Karlsson K, Old LJ, Lloyd KO. Analysis of a mouse monoclonal antibody detecting the H type 1 blood group determinant. Carbohydrate Research. 178: 333-336. PMID 2461256 DOI: 10.1016/0008-6215(88)80124-1 |
0.315 |
|
| 1987 |
Brook JD, Beresford HR, Shaw DJ, Old LJ, Rettig WJ. Localisation on human chromosome 19 of three genes for cell surface antigens defined by monoclonal antibodies Cytogenetic and Genome Research. 45: 156-162. PMID 3691180 DOI: 10.1159/000132447 |
0.416 |
|
| 1987 |
Klein CE, Cordon-Cardo C, Soehnchen R, Cote RJ, Oettgen HF, Eisinger M, Old LJ. Changes in cell surface glycoprotein expression during differentiation of human keratinocytes. The Journal of Investigative Dermatology. 89: 500-6. PMID 3668293 DOI: 10.1111/1523-1747.Ep12460996 |
0.378 |
|
| 1987 |
Welt S, Carswell EA, Vogel C, Oettgen HF, Old LJ. Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells Clinical Immunology and Immunopathology. 45: 214-229. PMID 3665201 DOI: 10.1016/0090-1229(87)90036-5 |
0.398 |
|
| 1987 |
Dropcho EJ, Chen Y, Posner JB, Old LJ. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration Proceedings of the National Academy of Sciences of the United States of America. 84: 4552-4556. PMID 3474619 DOI: 10.1073/Pnas.84.13.4552 |
0.334 |
|
| 1987 |
Darzynkiewicz Z, Carter SP, Old LJ. Effect of recombinant tumor necrosis factor on HL-60 cells: Cell-cycle specificity and synergism with actinomycin D Journal of Cellular Physiology. 130: 328-335. PMID 3470296 DOI: 10.1002/Jcp.1041300304 |
0.336 |
|
| 1987 |
Srivastava PK, Chen Y, Old LJ. 5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors. Proceedings of the National Academy of Sciences of the United States of America. 84: 3807-3811. PMID 2438686 DOI: 10.1073/Pnas.84.11.3807 |
0.366 |
|
| 1987 |
Darzynkiewicz Z, Staiano-Coico L, Kunicka JE, DeLeo AB, Old LJ. p53 content in relation to cell growth and proliferation in murine L1210 leukemia and normal lymphocytes. Leukemia Research. 10: 1383-9. PMID 2432361 DOI: 10.1016/0145-2126(86)90004-4 |
0.32 |
|
| 1986 |
Rettig WJ, Real FX, Spengler BA, Biedler JL, Old LJ. Human melanoma proteoglycan: expression in hybrids controlled by intrinsic and extrinsic signals. Science (New York, N.Y.). 231: 1281-4. PMID 3633135 DOI: 10.1126/Science.3633135 |
0.374 |
|
| 1986 |
Cordon-Cardo C, Lloyd KO, Sakamoto J, McGroarty ME, Old LJ, Melamed MR. Immunohistologic expression of blood-group antigens in normal human gastrointestinal tract and colonic carcinoma International Journal of Cancer. 37: 667-676. PMID 3516890 DOI: 10.1002/Ijc.2910370505 |
0.448 |
|
| 1986 |
Cote RJ, Morrissey DM, Houghton AN, Thomson TM, Daly ME, Oettgen HF, Old LJ. Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigens. Proceedings of the National Academy of Sciences of the United States of America. 83: 2959-63. PMID 3458255 DOI: 10.1073/Pnas.83.9.2959 |
0.477 |
|
| 1986 |
Srivastava PK, Deleo AB, Old LJ. Tumor rejection antigens of chemically induced sarcomas of inbred mice Proceedings of the National Academy of Sciences of the United States of America. 83: 3407-3411. PMID 3458189 DOI: 10.1073/Pnas.83.10.3407 |
0.413 |
|
| 1986 |
Rettig WJ, Thomson TM, Spengler BA, Biedler JL, Old LJ. Assignment of human nerve growth factor receptor gene to chromosome 17 and regulation of receptor expression in somatic cell hybrids. Somatic Cell and Molecular Genetics. 12: 441-7. PMID 3020711 DOI: 10.1007/Bf01539915 |
0.355 |
|
| 1986 |
Rubin BY, Anderson SL, Sullivan SA, Williamson BD, Carswell EA, Old LJ. Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor. The Journal of Experimental Medicine. 164: 1350-5. PMID 3020152 DOI: 10.1084/Jem.164.4.1350 |
0.328 |
|
| 1986 |
Morishita H, Shiku H, Horibe K, Obata Y, Stockert E, Oettgen HF, Old LJ, Yamada K. Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens. The Journal of Experimental Medicine. 163: 452-7. PMID 3003228 DOI: 10.1084/Jem.163.2.452 |
0.431 |
|
| 1985 |
Graus F, Cordon-Cardo C, Houghton AN, Melamed MR, Old LJ. Distribution of the ganglioside GD3 in the human nervous system detected by R24 mouse monoclonal antibody. Brain Research. 324: 190-4. PMID 6394100 DOI: 10.1016/0006-8993(84)90642-5 |
0.314 |
|
| 1985 |
Livingston PO, Kaelin K, Pinsky CM, Oettgen HF, Old LJ. The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines Cancer. 56: 2194-2200. PMID 4052966 DOI: 10.1002/1097-0142(19851101)56:9<2194::Aid-Cncr2820560910>3.0.Co;2-L |
0.441 |
|
| 1985 |
Thomson TM, Mattes MJ, Roux L, Old LJ, Lloyd KO. Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody Journal of Investigative Dermatology. 85: 169-174. PMID 3926906 DOI: 10.1111/1523-1747.Ep12276608 |
0.424 |
|
| 1985 |
Palladino MA, Ranges GE, Oettgen HF, Old LJ. Functional relationships of Lyt-2 and Lyt-3 expression and T-cell cytotoxicity: a new model system. Advances in Experimental Medicine and Biology. 184: 355-64. PMID 3875974 DOI: 10.1007/978-1-4684-8326-0_24 |
0.407 |
|
| 1985 |
Rettig WJ, Chesa PG, Jennings MT, Spengler BA, Melamed MR, Oettgen HF, Biedler JL, Old LJ. Cell surface antigen of human neuroblastomas is related to nuclear antigen of normal cells. Proceedings of the National Academy of Sciences of the United States of America. 82: 6894-8. PMID 3863134 DOI: 10.1073/Pnas.82.20.6894 |
0.417 |
|
| 1985 |
Finstad CL, Cordon-Cardo C, Bander NH, Whitmore WF, Melamed MR, Old LJ. Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proceedings of the National Academy of Sciences of the United States of America. 82: 2955-9. PMID 3857626 DOI: 10.1073/Pnas.82.9.2955 |
0.363 |
|
| 1985 |
Dracopoli NC, Houghton AN, Old LJ. Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity. Proceedings of the National Academy of Sciences of the United States of America. 82: 1470-4. PMID 2983346 DOI: 10.1073/Pnas.82.5.1470 |
0.327 |
|
| 1985 |
Livingston PO, Albino AP, Chung TJ, Real FX, Houghton AN, Oettgen HF, Old LJ. Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells. Cancer. 55: 713-20. PMID 2981601 DOI: 10.1002/1097-0142(19850215)55:4<713::Aid-Cncr2820550407>3.0.Co;2-D |
0.442 |
|
| 1985 |
Rettig WJ, Cordon-Cardo C, Koulos JP, Lewis JL, Oettgen HF, Old LJ. Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodies. International Journal of Cancer. 35: 469-75. PMID 2580800 DOI: 10.1002/Ijc.2910350409 |
0.443 |
|
| 1984 |
Knuth A, Danowski B, Oettgen HF, Old LJ. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures Proceedings of the National Academy of Sciences of the United States of America. 81: 3511-3515. PMID 6610177 DOI: 10.1073/Pnas.81.11.3511 |
0.402 |
|
| 1984 |
Rettig WJ, Dracopoli NC, Goetzger TA, Spengler BA, Biedler JL, Oettgen HF, Old LJ. Two cell-surface markers for human chromosome 1 in interspecies hybrids. Somatic Cell and Molecular Genetics. 10: 297-305. PMID 6585973 DOI: 10.1007/Bf01535251 |
0.392 |
|
| 1984 |
Fradet Y, Cordon-Cardo C, Thomson T, Daly ME, Whitmore WF, Lloyd KO, Melamed MR, Old LJ. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America. 81: 224-8. PMID 6364135 DOI: 10.1073/Pnas.81.1.224 |
0.452 |
|
| 1984 |
Houghton AN, Thomson TM, Gross D, Oettgen HF, Old LJ. Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon. The Journal of Experimental Medicine. 160: 255-69. PMID 6204001 DOI: 10.1084/Jem.160.1.255 |
0.407 |
|
| 1983 |
Livingston PO, Watanabe T, Shiku H, Houghton AN, Albino A, Takahashi T, Resnick LA, Michitsch R, Pinsky CM, Oettgen HF, Old LJ. Serological response of melanoma patients receiving melanoma cell vaccines. I. Autologous cultured melanoma cells. International Journal of Cancer. 30: 413-22. PMID 7141736 DOI: 10.1002/Ijc.2910300406 |
0.447 |
|
| 1983 |
Houghton AN, Brooks H, Cote RJ, Taormina MC, Oettgen HF, Old LJ. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma. The Journal of Experimental Medicine. 158: 53-65. PMID 6864164 DOI: 10.1084/Jem.158.1.53 |
0.456 |
|
| 1983 |
Livingston PO, Takeyama H, Pollack MS, Houghton AN, Albino A, Pinsky CM, Oettgen HF, Old LJ. Serological responses of melanoma patients to vaccines derived from allogeneic cultured melanoma cells. International Journal of Cancer. 31: 567-75. PMID 6852975 DOI: 10.1002/Ijc.2910310507 |
0.463 |
|
| 1983 |
Cote RJ, Morrissey DM, Houghton AN, Beattie EJ, Oettgen HF, Old LJ. Generation of human monoclonal antibodies reactive with cellular antigens. Proceedings of the National Academy of Sciences of the United States of America. 80: 2026-30. PMID 6572959 DOI: 10.1073/Pnas.80.7.2026 |
0.458 |
|
| 1983 |
Shen DW, Real FX, DeLeo AB, Old LJ, Marks PA, Rifkind RA. Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division. Proceedings of the National Academy of Sciences of the United States of America. 80: 5919-22. PMID 6351070 DOI: 10.1073/Pnas.80.19.5919 |
0.313 |
|
| 1983 |
Flood PM, Deleo AB, Old LJ, Gershon RK. Similarities between Transplantation Antigens on Methylcholanthrene‐Induced Sarcomas and T‐Cell Regulatory Molecules Annals of the New York Academy of Sciences. 418: 206-219. PMID 6231877 DOI: 10.1111/J.1749-6632.1983.Tb18068.X |
0.39 |
|
| 1983 |
Flood PM, DeLeo AB, Old LJ, Gershon RK. Relation of cell surface antigens on methylcholanthrene-induced fibrosarcomas to immunoglobulin heavy chain complex variable region-linked T cell interaction molecules. Proceedings of the National Academy of Sciences of the United States of America. 80: 1683-1687. PMID 6220407 DOI: 10.1073/Pnas.80.6.1683 |
0.4 |
|
| 1983 |
Mattes MJ, Cairncross JG, Old LJ, Lloyd KO. Monoclonal Antibodies to Three Widely Distributed Human Cell Surface Antigens Hybridoma. 2: 253-264. PMID 6205978 DOI: 10.1089/Hyb.1983.2.253 |
0.447 |
|
| 1983 |
Mattes MJ, Thomson TM, Old LJ, Lloyd KO. A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. International Journal of Cancer. 32: 717-721. PMID 6197381 DOI: 10.1002/Ijc.2910320610 |
0.455 |
|
| 1983 |
Williamson BD, Carswell EA, Rubin BY, Prendergast JS, Old LJ. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proceedings of the National Academy of Sciences of the United States of America. 80: 5397-401. PMID 6193516 DOI: 10.1073/Pnas.80.17.5397 |
0.351 |
|
| 1982 |
Watanabe T, Pukel CS, Takeyama H, Lloyd KO, Shiku H, Li LTC, Travassos LR, Oettgen HF, Old LJ. Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. Journal of Experimental Medicine. 156: 1884-1889. PMID 7175442 DOI: 10.1084/Jem.156.6.1884 |
0.456 |
|
| 1982 |
Deleo AB, Chang KSS, Wivel NA, Appella E, Old LJ, Law LW. possible role of a retrovirus in the expression of tumor-specific antigens of the Meth A sarcoma. International Journal of Cancer. 29: 687-693. PMID 7107069 DOI: 10.1002/Ijc.2910290615 |
0.448 |
|
| 1982 |
Pukel CS, Lloyd KO, Travassos LR, Dippold WG, Oettgen HF, Old LJ. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. Journal of Experimental Medicine. 155: 1133-1147. PMID 7061953 DOI: 10.1084/Jem.155.4.1133 |
0.449 |
|
| 1982 |
Anger BR, Lloyd KO, Oettgen HF, Old LJ. Mouse monoclonal IgM antibody against human lung cancer line SK-LC-3 with specificity for H(O) blood group antigen. Hybridoma. 1: 139-47. PMID 6208122 DOI: 10.1089/Hyb.1.1982.1.139 |
0.38 |
|
| 1982 |
Jay G, Palladino MA, Khoury G, Old LJ. Mouse Lyt-2 antigen: evidence for two heterodimers with a common subunit. Proceedings of the National Academy of Sciences of the United States of America. 79: 2654-7. PMID 6178108 DOI: 10.1073/Pnas.79.8.2654 |
0.36 |
|
| 1981 |
Pravtcheva DD, DeLeo AB, Ruddle FH, Old LJ. Chromosome assignment of the tumor-specific antigen of a 3-methylcholanthrene-induced mouse sarcoma. The Journal of Experimental Medicine. 154: 964-77. PMID 7276830 DOI: 10.1084/Jem.154.3.964 |
0.375 |
|
| 1981 |
Ueda R, Ogata S, Morrissey DM, Finstad CL, Szkudlarek J, Whitmore WF, Oettgen HF, Lloyd KO, Old LJ. Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins Proceedings of the National Academy of Sciences of the United States of America. 78: 5122-5126. PMID 6946460 DOI: 10.1073/Pnas.78.8.5122 |
0.433 |
|
| 1981 |
Dippold WG, Jay G, DeLeo AB, Khoury G, Old LJ. p53 transformation-related protein: Detection by monoclonal antibody in mouse and human cells Proceedings of the National Academy of Sciences of the United States of America. 78: 1695-1699. PMID 6940183 DOI: 10.1073/Pnas.78.3.1695 |
0.372 |
|
| 1981 |
O'Donnell PV, Stockert E, Obata Y, Old LJ. Leukemogenic properties of AKR dualtropic (MCF) viruses: amplification of murine leukemia virus-related antigens on thymocytes and acceleration of leukemia development in AKR mice. Virology. 112: 548-563. PMID 6266139 DOI: 10.1016/0042-6822(81)90301-9 |
0.392 |
|
| 1981 |
Jay G, Khoury G, Deleo AB, Dippold WG, Old LJ. p53 transformation-related protein: detection of an associated phosphotransferase activity Proceedings of the National Academy of Sciences of the United States of America. 78: 2932-2936. PMID 6265926 DOI: 10.1073/Pnas.78.5.2932 |
0.348 |
|
| 1980 |
Pfreundschuh M, Shiku H, Takahashi T, Ueda R, Ransohoff J, Oettgen HF, Old LJ. Tumor-specific antigens. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrã¨S Dans Les Recherches Sur Le Cancer. 75: 1-9. PMID 7232821 DOI: 10.1007/978-3-642-81491-4_1 |
0.442 |
|
| 1980 |
Nakayama E, Dippold W, Shiku H, Oettgen HF, Old LJ. Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera Proceedings of the National Academy of Sciences of the United States of America. 77: 2890-2894. PMID 6967215 DOI: 10.1073/Pnas.77.5.2890 |
0.364 |
|
| 1980 |
Oettgen HF, Old LJ. Immunotherapy of colon cancer: prospects for developing immunogenic vaccines based on autologous serological typing. Cancer. 45: 1218-1222. PMID 6153566 DOI: 10.1002/1097-0142(19800315)45:5+<1218::Aid-Cncr2820451329>3.0.Co;2-C |
0.402 |
|
| 1979 |
Lloyd KO, Travassos LR, Takahashi T, Old LJ. Cell Surface Glycoproteins of Human Tumor Cell Lines: Unusual Characteristics of Malignant Melanoma Journal of the National Cancer Institute. 63: 623-634. PMID 381752 DOI: 10.1093/Jnci/63.3.623 |
0.393 |
|
| 1979 |
Carey TE, Lloyd KO, Takahashi T, Travassos LR, Old LJ. AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization. Proceedings of the National Academy of Sciences of the United States of America. 76: 2898-902. PMID 313568 DOI: 10.1073/Pnas.76.6.2898 |
0.384 |
|
| 1979 |
Deleo AB, Jay G, Appella E, Dubois GC, Law LW, Old LJ. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proceedings of the National Academy of Sciences of the United States of America. 76: 2420-2424. PMID 221923 DOI: 10.1073/Pnas.76.5.2420 |
0.358 |
|
| 1979 |
Nakayama E, Shiku H, Takahashi T, Oettgen HF, Old LJ. Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity Proceedings of the National Academy of Sciences of the United States of America. 76: 3486-3490. PMID 91166 DOI: 10.1073/Pnas.76.7.3486 |
0.404 |
|
| 1979 |
Nakayama E, Shiku H, Stockert E, Oettgen HF, Old LJ. Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera Proceedings of the National Academy of Sciences of the United States of America. 76: 1977-1981. PMID 88050 DOI: 10.1073/Pnas.76.4.1977 |
0.419 |
|
| 1978 |
Winchester RJ, Wang CY, Gibofsky A, Kunkel HG, Lloyd KO, Old LJ. Expression of Ia-like antigens on cultured human malignant melanoma cell lines. Proceedings of the National Academy of Sciences of the United States of America. 75: 6235-9. PMID 366616 DOI: 10.1073/Pnas.75.12.6235 |
0.372 |
|
| 1978 |
Pfreundschuh M, Shiku H, Takahashi T, Ueda R, Ransohoff J, Oettgen HF, Old LJ. Serological analysis of cell surface antigens of malignant human brain tumors. Proceedings of the National Academy of Sciences of the United States of America. 75: 5122-6. PMID 283420 DOI: 10.1073/Pnas.75.10.5122 |
0.451 |
|
| 1978 |
Risser R, Stockert E, Old LJ. Abelson antigen: a viral tumor antigen that is also a differentiation antigen of BALB/c mice. Proceedings of the National Academy of Sciences of the United States of America. 75: 3918-3922. PMID 211509 DOI: 10.1073/Pnas.75.8.3918 |
0.442 |
|
| 1977 |
Hoffmann MK, Oettgen HF, Old LJ, Chin AF, Hammerling U. Endotoxin-induced serum factor controlling differentiation of bone-marrow-derived lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 74: 1200-1203. PMID 322150 DOI: 10.1073/Pnas.74.3.1200 |
0.375 |
|
| 1977 |
Old LJ, Stockert E. Immunogenetics of cell surface antigens of mouse leukemia. Annual Review of Genetics. 11: 127-160. PMID 202188 DOI: 10.1146/Annurev.Ge.11.120177.001015 |
0.4 |
|
| 1977 |
DeLEO AB, Shiku H, Takahashi T, John M, Old LJ. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. Journal of Experimental Medicine. 146: 720-734. PMID 197192 DOI: 10.1084/Jem.146.3.720 |
0.419 |
|
| 1977 |
Stockert E, Old LJ. Preleukemic expression of TL antigens in x-irradiated C57BL/6 mice. Journal of Experimental Medicine. 146: 271-276. PMID 195001 DOI: 10.1084/Jem.146.1.271 |
0.359 |
|
| 1976 |
Kawashima K, Ikeda H, Hartley JW, Stockert E, Rowe WP, Old LJ. Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice. Proceedings of the National Academy of Sciences of the United States of America. 73: 4680-4. PMID 188051 DOI: 10.1073/Pnas.73.12.4680 |
0.342 |
|
| 1976 |
Kawashima K, Ikeda H, Stockert E, Takahashi T, Old LJ. Age-related changes in cell surface antigens of preleukemic AKR thymocytes. Journal of Experimental Medicine. 144: 193-208. PMID 180229 DOI: 10.1084/Jem.144.1.193 |
0.378 |
|
| 1976 |
Shiku H, Takahashi T, Bean MA, Old LJ, Oettgen HF. Ly phenotype of cytotoxic T cells for syngeneic tumor. Journal of Experimental Medicine. 144: 1116-1120. PMID 62011 DOI: 10.1084/Jem.144.4.1116 |
0.389 |
|
| 1975 |
Helson L, Green S, Carswell E, Old LJ. Effect of tumour necrosis factor on cultured human melanoma cells Nature. 258: 731-732. PMID 1207755 DOI: 10.1038/258731A0 |
0.308 |
|
| 1975 |
Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proceedings of the National Academy of Sciences of the United States of America. 72: 3666-70. PMID 1103152 DOI: 10.1073/Pnas.72.9.3666 |
0.328 |
|
| 1975 |
Shiku H, Bean MA, Old LJ, Oettgen HF. Cytotoxic Reactions of Murine Lymphoid Cells Studied With a Tritiated Proline Microcytotoxicity Test Journal of the National Cancer Institute. 54: 415-425. DOI: 10.1093/Jnci/54.2.415 |
0.378 |
|
| 1973 |
Komuro K, Boyse EA, Old LJ. Production of TL antibody by mice immunized with TL- cell populations. A possible assay for thymic hormone. Journal of Experimental Medicine. 137: 533-536. PMID 4685707 DOI: 10.1084/Jem.137.2.533 |
0.421 |
|
| 1972 |
Edynak EM, Old LJ, Vrana M, Lardis MP. A fetal antigen associated with human neoplasia. The New England Journal of Medicine. 286: 1178-1183. PMID 4623227 DOI: 10.1056/Nejm197206012862203 |
0.402 |
|
| 1972 |
Scheid M, Boyse EA, Carswell EA, Old LJ. Serologically demonstrable alloantigens of mouse epidermal cells. Journal of Experimental Medicine. 135: 938-955. PMID 4553016 DOI: 10.1084/Jem.135.4.938 |
0.385 |
|
| 1972 |
Rogers R, Merigan TC, Hardy WD, Old LJ, Kassel R. Cat interferon inhibits feline leukaemia virus infection in cell culture Nature: New Biology. 237: 270-271. PMID 4504461 DOI: 10.1038/Newbio237270A0 |
0.334 |
|
| 1972 |
Stockert E, Sato H, Itakura K, Boyse EA, Old LJ, Hutton JJ. Location of the Second Gene Required for Expression of the Leukemia-Associated Mouse Antigen GIX Science. 178: 862-863. PMID 4343697 DOI: 10.1126/Science.178.4063.862 |
0.376 |
|
| 1971 |
Stockert E, Old LJ, Boyse EA. The Gix System A Cell Surface Allo-Antigen Associated With Murine Leukemia Virus; Implications Regarding Chromosomal Integration Of The Viral Genome Journal of Experimental Medicine. 133: 1334-1355. PMID 5576334 DOI: 10.1084/Jem.133.6.1334 |
0.379 |
|
| 1971 |
Stackpole CW, Aoki T, Boyse EA, Old LJ, Lumley-Frank J, De Harven E. Cell surface antigens: serial sectioning of single cells as an approach to topographical analysis. Science (New York, N.Y.). 172: 472-4. PMID 5550501 DOI: 10.1126/Science.172.3982.472 |
0.382 |
|
| 1971 |
Itakura K, Hutton JJ, Boyse EA, Old LJ. Linkage groups of the theta and Ly-A loci Nature: New Biology. 230: 126. PMID 5279341 DOI: 10.1038/Newbio230126A0 |
0.343 |
|
| 1971 |
Oettgen HF, Old LJ, Boyse EA. Human Tumor Immunology Medical Clinics of North America. 55: 761-785. PMID 4995918 DOI: 10.1016/S0025-7125(16)32516-0 |
0.319 |
|
| 1971 |
Takahashi T, Old LJ, Hsu C‐, Boyse EA. A new differentiation antigen of plasma cells. European Journal of Immunology. 1: 478-482. PMID 4947913 DOI: 10.1002/Eji.1830010614 |
0.421 |
|
| 1971 |
Takahashi T, Old LJ, McIntire KR, Boyse EA. Immunoglobulin and other surface antigens of cells of the immune system. Journal of Experimental Medicine. 134: 815-832. PMID 4106485 DOI: 10.1084/Jem.134.4.815 |
0.437 |
|
| 1971 |
Nowinski RC, Sarkar NH, Old LJ, Moore DH, Scheer DI, Hilgers J. Characteristics of the structural components of the mouse mammary tumor virus. II. Viral proteins and antigens Virology. 46: 21-38. DOI: 10.1016/0042-6822(71)90003-1 |
0.367 |
|
| 1970 |
Takahashi T, Old LJ, Boyse EA. Surface Alloantigens Of Plasma Cells Journal of Experimental Medicine. 131: 1325-1341. PMID 5419273 DOI: 10.1084/Jem.131.6.1325 |
0.395 |
|
| 1970 |
Bloom BR, Bennett B, Oettgen HF, McLean EP, Old LJ. Demonstration of delayed hypersensitivity to soluble antigens of chemically induced tumors by inhibition of macrophage migration. Proceedings of the National Academy of Sciences of the United States of America. 64: 1176-80. PMID 5271746 DOI: 10.1073/Pnas.64.4.1176 |
0.385 |
|
| 1970 |
Aoki T, Boyse EA, Old LJ, De Harven E, Hämmerling U, Wood HA. G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proceedings of the National Academy of Sciences of the United States of America. 65: 569-76. PMID 5267138 DOI: 10.1073/Pnas.65.3.569 |
0.412 |
|
| 1970 |
Boyse EA, Lance EM, Carswell EA, Cooper S, Old LJ. Rejection of skin allografts by radiation chimaeras: selective gene action in the specification of cell surface structure. Nature. 227: 901-903. PMID 4915405 DOI: 10.1038/227901A0 |
0.307 |
|
| 1970 |
Geering G, Aoki T, Old LJ. Shared Viral Antigen of Mammalian Leukaemia Viruses Nature. 226: 265-266. PMID 4314416 DOI: 10.1038/226265A0 |
0.354 |
|
| 1970 |
Bloom BR, Bennett B, Oettgen HF, McLean EP, Old LJ. Demonstration of delayed hypersensitivity to soluble antigens of chemically induced tumors by inhibition of macrophage migration Transplantation. 10: 271. DOI: 10.1097/00007890-197009000-00010 |
0.352 |
|
| 1970 |
Carswell EA, Wanebo HJ, Old LJ, Boyse EA. Immunogenic Properties of Reticulum Cell Sarcomas of SJL/J Mice Journal of the National Cancer Institute. 44: 1281-1288. DOI: 10.1093/Jnci/44.6.1281 |
0.3 |
|
| 1969 |
Hämmerling U, Aoki T, Wood HA, Old LJ, Boyse EA, de Harvin E. New visual markers of antibody for electron microscopy. Nature. 223: 1158-9. PMID 5810691 DOI: 10.1038/2231158A0 |
0.383 |
|
| 1969 |
Aoki T, Hämmerling U, Harven Ed, Boyse EA, Old LJ. Antigenic structure of cell surfaces, an immunoferritin study of the occurrence and topography of h-2, theta, and tl alloantigens on mouse cells. Journal of Experimental Medicine. 130: 979-1001. PMID 5347699 DOI: 10.1084/Jem.130.5.979 |
0.361 |
|
| 1969 |
Hardy WD, Geering G, Old LJ, Harven ED, Brodey RS, McDonough S. Feline leukemia virus: occurrence of viral antigen in the tissues of cats with lymphosarcoma and other diseases. Science. 166: 1019-1021. PMID 4981495 DOI: 10.1126/Science.166.3908.1019 |
0.324 |
|
| 1969 |
Gregoriades A, Old LJ. Isolation and some characteristics of a group-specific antigen of the murine leukemia viruses. Virology. 37: 189-202. PMID 4974327 DOI: 10.1016/0042-6822(69)90198-6 |
0.314 |
|
| 1968 |
Oettgen HF, Old LJ, Mclean EP, Carswell EA. Delayed hypersensitivity and transplantation immunity elicited by soluble antigens of chemically induced tumours in inbred guinea-pigs. Nature. 220: 295-297. PMID 5684864 DOI: 10.1038/220295A0 |
0.373 |
|
| 1968 |
Old LJ, Boyse EA. Prospects for Immunotherapy of Human Cancer Annals of Internal Medicine. 69: 393-397. PMID 5667775 DOI: 10.7326/0003-4819-69-2-393 |
0.38 |
|
| 1968 |
Boyse EA, Stockert E, Old LJ. Isoantigens of the H-2 and Tla loci of the mouse: interactions affecting their representation on thymocytes. Journal of Experimental Medicine. 128: 85-95. PMID 5662018 DOI: 10.1084/Jem.128.1.85 |
0.319 |
|
| 1968 |
Old LJ, Stockert E, Boyse EA, Kim JH. Antigenic Modulation Loss Of Tl Antigen From Cells Exposed To Tl Antibody. Study Of The Phenomenon In Vitro Journal of Experimental Medicine. 127: 523-539. PMID 5636556 DOI: 10.1084/Jem.127.3.523 |
0.394 |
|
| 1968 |
Boyse EA, Old LJ, Stockert E. An approach to the mapping of antigens on the cell surface. Proceedings of the National Academy of Sciences of the United States of America. 60: 886-893. PMID 5243930 DOI: 10.1073/Pnas.60.3.886 |
0.398 |
|
| 1968 |
Hämmerling U, Aoki T, Harven Ed, Boyse EA, Old LJ. USE OF HYBRID ANTIBODY WITH ANTI-γG AND ANTI-FERRITIN SPECIFICITIES IN LOCATING CELL SURFACE ANTIGENS BY ELECTRON MICROSCOPY Journal of Experimental Medicine. 128: 1461-1473. PMID 4972125 DOI: 10.1084/Jem.128.6.1461 |
0.392 |
|
| 1968 |
Boyse EA, Miyazawa M, Aoki T, Old LJ. Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proceedings of the Royal Society B: Biological Sciences. 170: 175-193. PMID 4385242 DOI: 10.1098/Rspb.1968.0032 |
0.4 |
|
| 1968 |
Geering G, Hardy WD, Old LJ, Harven Ed, Brodey RS. Shared group-specific antigen of murine and feline leukemia viruses Virology. 36: 678-680. PMID 4302005 DOI: 10.1016/0042-6822(68)90199-2 |
0.345 |
|
| 1968 |
Nowinski RC, Old LJ, Boyse EA, Harven Ed, Geering G. Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus. Virology. 34: 617-629. PMID 4297122 DOI: 10.1016/0042-6822(68)90083-4 |
0.317 |
|
| 1968 |
Nowinski RC, Boyse EA, Old LJ, Carswell EA. Influence of Mammary Tumor Virus Infection on the Acceptance or Rejection of Transplanted ML+ Leukemias Experimental Biology and Medicine. 127: 20-25. PMID 4296245 DOI: 10.3181/00379727-127-32611 |
0.318 |
|
| 1968 |
Shigeno N, Hämmerling U, Arpels C, Boyse E, Old L. Preparation Of Lymphocyte-Specific Antibody From Anti-Lymphocyte Serum The Lancet. 292: 320-323. PMID 4173737 DOI: 10.1016/S0140-6736(68)90530-8 |
0.324 |
|
| 1968 |
Oettgen HF, Aoki T, Old LJ, Boyse EA, Harven Ed, Mills GM. Suspension Culture of a Pigment-Producing Cell Line Derived From a Human Malignant Melanoma Journal of the National Cancer Institute. 41: 827-843. DOI: 10.1093/Jnci/41.4.827 |
0.31 |
|
| 1967 |
Davies DA, Boyse EA, Old LJ, Stockert E. Mouse isoantigens: separation of soluble TL (thymus-leukemia) antigen from soluble H-2 histocompatibility antigen by column chromatography. The Journal of Experimental Medicine. 125: 549-58. PMID 6020006 DOI: 10.1084/Jem.125.4.549 |
0.344 |
|
| 1967 |
Old LJ, Stockert E, Boyse EA, Geering G. A study of passive immunization against a transplanted G+ leukemia with specific antiserum. Experimental Biology and Medicine. 124: 63-68. PMID 6017793 DOI: 10.3181/00379727-124-31667 |
0.372 |
|
| 1967 |
Boyse EA, Stockert E, Old LJ. Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody. Proceedings of the National Academy of Sciences of the United States of America. 58: 954-957. PMID 5233851 DOI: 10.1073/Pnas.58.3.954 |
0.376 |
|
| 1966 |
Old LJ, Boyse EA, Oettgen HF, Harven ED, Geering G, Williamson B, Clifford P. Precipitating Antibody In Human Serum To An Antigen Present In Cultured Burkitt'S Lymphoma Cells Proceedings of the National Academy of Sciences of the United States of America. 56: 1699-1704. PMID 16591407 DOI: 10.1073/Pnas.56.6.1699 |
0.39 |
|
| 1966 |
Old LJ, Boyse EA. Specific antigens of tumors and leukemias of experimental animals. Medical Clinics of North America. 50: 901-912. PMID 5325283 DOI: 10.1016/S0025-7125(16)33187-X |
0.381 |
|
| 1966 |
Wanebo HJ, Gallmeier WM, Boyse EA, Old LJ. Paraproteinemia and Reticulum Cell Sarcoma in an Inbred Mouse Strain Science. 154: 901-903. PMID 4886826 DOI: 10.1126/Science.154.3751.901 |
0.33 |
|
| 1966 |
Geering G, Old LJ, Boyse EA. Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses. Journal of Experimental Medicine. 124: 753-772. PMID 4288480 DOI: 10.1084/Jem.124.4.753 |
0.412 |
|
| 1965 |
Schlesinger M, Boyse EA, Old LJ. Thymus Cells of Radiation-Chimeras: TL Phenotype, Sensitivity to Guinea-Pig Serum, and Origin from Donor Cells Nature. 206: 1119-1121. PMID 5325443 DOI: 10.1038/2061119A0 |
0.316 |
|
| 1964 |
Stück B, Old LJ, Boyse EA. Occurrence Of Soluble Antigen In The Plasma Of Mice With Virus-Induced Leukemia. Proceedings of the National Academy of Sciences of the United States of America. 52: 950-958. PMID 14224399 DOI: 10.1073/Pnas.52.4.950 |
0.301 |
|
| 1964 |
Stück B, Boyse EA, Old LJ, Carswell EA. ML: A New Antigen Found in Leukæmias and Mammary Tumours of the Mouse Nature. 203: 1033-1034. PMID 14223070 DOI: 10.1038/2031033A0 |
0.355 |
|
| 1964 |
Stück B, Old LJ, Boyse EA. Antigenic Conversion of Established Leukæmias by an Unrelated Leukæmogenic Virus Nature. 202: 1016-1018. PMID 14197309 DOI: 10.1038/2021016B0 |
0.388 |
|
| 1964 |
Boyse EA, Old LJ, Luell S. Mouse Leukæmias: Genetic Determination of the TL (Thymus-leukæmia) Antigen in the Mouse Nature. 201: 779-779. PMID 14161199 DOI: 10.1038/201779A0 |
0.334 |
|
| 1964 |
Bennett B, Old LJ, Boyse EA. The Phagocytosis Of Tumor Cells In Vitro. Transplantation. 2: 183-202. PMID 14133142 DOI: 10.1097/00007890-196403000-00003 |
0.355 |
|
| 1963 |
Bennett B, Old LJ, Boyse EA. Opsonization of cells by isoantibody in vitro. Nature. 198: 10-12. PMID 13967460 DOI: 10.1038/198010A0 |
0.33 |
|
| 1963 |
Boyse EA, Old LJ, Luell S. Antigenic Properties of Experimental Leukemias. II. Immunological Studies In Vivo With C57BL/6 Radiation-Induced Leukemias Journal of the National Cancer Institute. 31: 987-995. DOI: 10.1093/Jnci/31.4.987 |
0.408 |
|
| 1963 |
Old LJ, Boyse EA, Stockert E. Antigenic Properties Of Experimental Leukemias. I. Serological Studies In Vitro With Spontaneous And Radiation-Induced Leukemias. Journal of the National Cancer Institute. 31: 977-986. DOI: 10.1093/Jnci/31.4.977 |
0.307 |
|
| 1962 |
Chouroulinkov I, Boyse EA, Old LJ. Cytotoxic activity of isoantibody on sarcoma I. Experimental Biology and Medicine. 111: 263-265. PMID 14021040 DOI: 10.3181/00379727-111-27762 |
0.316 |
|
| Show low-probability matches. |